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This dissertation discusses the use of microreactors and microcapsules in the context 
of multicatalyst systems.  The first two chapters focus on organic synthesis in 
microfluidic devices, whose modular design offers the possibility for performing 
sequential reactions in flow.  In the first example, the unique behavior of fluids at 
small dimensions was taken advantage of in order to prevent solid products from 
clogging the microfluidic channels.  By performing reactions in dispersed droplets 
surrounded by a carrier phase, the precipitated products were kept away from the 
channel walls, preventing channel clogging.  The second chapter describes the 
synthesis of ibuprofen and atropine as multi-step syntheses in flow.  In addition to the 
successful synthesis of both of these products, this project resulted in the development 
of a solid-supported reagent that has the potential to enable multi-step synthesis in 
flow.  The second focus of this work involves microencapsulated catalysts.  The 
theory behind this approach is that the encapsulation of large polymeric catalysts 
within polymer shells would prevent catalysts from interacting with each other, 
allowing for the use of multiple catalysts in one reaction vessel.  The synthesis of a 
microencapsulated polyamine catalyst is described, and the development of a two-
step, one-pot reaction is discussed.  This multistep reaction, consisting of nitroalkene 
formation and a Michael reaction, produces γ-amino acid precursors that cannot be 
obtained if the polyamine catalyst in not encapsulated.  In addition to catalyzing 
nitroalkene formation, the microencapsulated catalyst was found to enhance the rate of 
the Michael addition.  Initially attributed to the ureas of the polyurea capsule, it was 
discovered that the rate enhancement was due to the amine groups.  However, a small 
molecule bifunctional urea was developed that was found to provide rate enhancement 
for the proline-catalyzed α-aminoxylation of aldehydes.  Experimental evidence 
suggests that the origin of the rate enhancement is due to interaction between the urea 
and an oxazolidinone and may be general for other proline-catalyzed reactions 
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Solving the Clogging Problem: Precipitate-Forming Reactions in Flow 
 
Preface 
 In early 2005, former McQuade group members Elizabeth Quevedo and 
Jeremy Steinbacher developed a microfluidic device consisting of syringe pumps, 
syringes, needles, and tubing.  This device was readily adaptable, relatively 
inexpensive, and capable of performing interfacial polymerization in flow to produce 
polyamide microcapsules.  The work described in this chapter builds upon their 




 This work describes a method by which solids can be produced in flow.  A 
monodisperse flow in a microreactor provides an efficient method for keeping solid 
products away from channel walls.  The use of a carrier phase, such as mineral oil, 
hexane, or toluene, enables solids to be synthesized without clogging of the reactor 
channels.  The synthesis of indigo, N,N’-dicyclohexylethylenediimine, and 4-chloro-
N-methylbenzamide are discussed. 
 
Introduction* 
Techniques developed in recent decades have done little to change the 
fundamental processes of chemistry.  Reaction vessels of a century ago continue to be 
                                                
* Poe, S. L.; Cummings, M. A.; Haaf, M. P.; McQuade, D. T.: Solving the Clogging 
Problem: Precipitate-Forming Reactions in Flow. Angew. Chem. Int. Ed. 2006, 45, 
1544-1548. Copyright 2006 Wiley-VCH Verlag GmbH & Co. KGaA. Reproduced 
with permission. 
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the standard reactors of today.  Recently, however, increasing attention has been paid 
to chemical reactions performed in microreactors.1-6  Reactions are performed in these 
microfluidic devices by flowing reactants through channels that generally range in size 
from 10 to 500 mm.  On account of its small proportions, a flat microchannel with a 
width of 100 mm has a specific surface-area-to-volume ratio that is 200 times larger 
than that of a 100-mL flask and over 3000 times larger than a tank that occupies a 
cubic meter.7  This increased surface-area-to volume ratio allows for better molecular 
diffusion and heat transfer properties, which allow faster and more-selective chemical 
reactions.8,9  
From an industrial standpoint, microreactors are advantageous because they 
eliminate the need to scale up a reaction.  Whereas in traditional process chemistry 
bench-top syntheses must be redesigned for industrial compatibility, a method known 
as numbering-up involves the addition of microreactors to achieve the desired 
throughput.10  As every reactor is identical to the pilot reactor, there is no need to 
change dimensions or conditions.  Other advantages include increased safety,11 lower 
costs, and more environmentally friendly chemistry owing to efficient reactions that 
require less solvent. 
Despite the numerous advantages of microreactors, they are not without their 
drawbacks.12,13  Researchers in an academic setting have been slow to embrace these 
systems because of their cost and inflexibility.14  The manufacture of a single 
microreactor can be a very time- and cost-intensive process, and once a microreactor 
has been developed, there is rarely any opportunity to make variations to the device.15  
Another commonly cited concern is the clogging of the channels that occurs upon 
precipitate formation.16  The handling and processing of solids make up a significant 
proportion of laboratory and industrial processes, and current microreactor technology 
is not yet ready to handle these syntheses efficiently.17  There has recently been an 
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increased effort to deal with this problem, although many industrial solutions come at 
a large expense.  A less expensive approach incorporates a periodic purging step to 
flush out solids that have formed on the channel walls.18  However, this method is not 
effective if significant solid buildup occurs before purging.  A more attractive 
alternative involves performing reactions in droplets that travel through the 
microreactor channels inside a carrier phase.19 
Fluid fields generated in microfluidic devices can control reagent mixing20 and 
allow the formation of an emulsion upon the collision of two immiscible liquids.  We 
have recently reported a simple microfluidic device that can replicate these flow 
phenomena.21  Our device is composed of syringe pumps, syringes, needles, and 
ordinary laboratory tubing—all of which are relatively inexpensive and commercially 
available (Figure 1.1).  Development of our microreactor to facilitate chemical 
syntheses would potentially ameliorate some of the problems still plaguing 
microreactors, namely their cost and channel clogging.  By utilizing disperse-phase 
droplets as individual reactors, we can confine the solid products to these droplets, 
thus keeping them away from the tubing walls and avoiding clogged channels.  
Herein, we present the results of the first chemical syntheses performed in our 
microreactor and show that our device is practical and efficient for the production of 






Figure 1.1. Basic design of our microfluidic reactor.  The top-left syringe pump 
contains the carrier phase, the right pump contains the first disperse phase, and the 
bottom-left pump contains the second disperse phase.  Reagents are injected through a 
30-gauge blunt-edge needle (see inset). 
 
Results and Discussion 
By nature of its design, our microfluidic device is versatile, bearing the 
essential features of the reactor illustrated in Figure 1.1.  Additional fluid junctions 
may be added as needed simply by inserting a needle anywhere along the tubing.  To 
demonstrate the suitability of our device for the synthesis of solid particles, we chose a 
simple system in which aqueous reagents combine to form a solid precipitate.  Having 
successfully demonstrated the ability to synthesize solids by interfacial polymerization 
in a two-flow system,21 we took advantage of the versatility of our device and added a 
third fluid flow.  In each case, an inert carrier fluid was employed as the continuous 
phase, and disperse-phase reagents were injected into the tubing through separate 
syringe pumps located downstream from the carrier-phase source.  Reagent mixing 
occurred in one of two ways.  If both disperse phases are immiscible with the carrier 
phase, the mixing of the reagents is initiated by the collision of two different reagent 
phase droplets (Figure 1.2a).  This type of mixing was observed when mineral oil was 
used as the carrier phase.  On the other hand, reagents that are miscible with the carrier 
phase are injected coaxially as the final reagent.  In this case, the mixing is caused 
both by infusion of the second reagent into the first and by diffusion from the carrier 
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phase into the disperse phase (Figure 1.2b).  In both of these cases, chaotic advection 
could be induced by passing the fluid stream through winding tubing (Figure 1.2c).23  
We used 30-gauge (0.15 mm i.d.) blunt edge needles for reagent introduction to obtain 




Figure 1.2.  Reagents are mixed inside the tubing by droplet–droplet collision (a) or 
infusion followed by diffusion (b).  Mixing can be enhanced by chaotic advection 
induced by passing the reaction stream through winding tubing (c). 
 
A number of research groups have employed fluorinated solvents as carrier 
phases for microfluidic processes to minimize the possibility of side reactions.24  
These solvents, however, can be expensive and are rarely used as common laboratory 
reagents.  Instead, we chose mineral oil, hexane (mixture of isomers), and toluene as 
relatively inert and readily available carrier phases.   
The first reaction we performed was the synthesis of indigo (3), which involves 
a base-catalyzed aldol condensation between acetone (1) and 2-nitrobenzaldehyde (2; 














Scheme 1.1.  Synthesis of indigo (3). 
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The synthesis of this dye was appealing not only because it results in the precipitation 
of a solid, but also because the product stains the poly(vinyl chloride) (PVC) tubing 
upon contact, which provides an easy means of determining the effectiveness of our 
method for isolating the solid from the channel walls.  We found that a mineral oil 
flow rate of 3 mL/min produces sufficiently small droplets that are confined to the 
center of the tubing. Figure 1.3 illustrates the differences observed when indigo is 
synthesized in the presence and absence of a carrier phase.  The reagent collision 
shown in Figure 1.2 a and b induces some mixing of the reagents. It has been shown 
that a further enhancement is observed when the droplets are flowed through a 
winding channel, which causes mixing by chaotic advection.23  We observed a 
qualitatively similar phenomenon when we wound our tubing through a series of 
parallel horizontal bars.  When the indigo synthesis was performed inside this tubing, 
the indigo formation (observed by a color change) occurred more rapidly than it did in 
straight tubing.  Characterization was not performed for this reaction due to well-
established purification issues.25 
 
 
Figure 1.3.  Demonstration of the effectiveness of the carrier phase in the formation of 
solids.  Comparison of the tubing during (left tube) and after (right tube) the synthesis 




This method of producing solids in microreactors by using a monodisperse 
droplet flow can be extended to carrier phases other than mineral oil.  The reaction of 
glyoxal (4) with cyclohexylamine (5) results in the precipitation of N,N’-







Scheme 1.2.  Synthesis of N,N’-dicyclohexylethylenediimine (6). 
 
When mineral oil is used as the carrier phase, the droplet–droplet phenomenon shown 
in Figure 1.2a is observed.  However, as 6 is soluble in mineral oil, product recovery is 
difficult.  In contrast, the use of hexane (mixture of isomers) as the carrier phase 
allows both the formation of solid in the monodisperse flow as well as easier 
extraction of the solid.  Owing to the decreased viscosity and density of the hexane 
carrier phase relative to mineral oil, higher flow rates are required to achieve the 
desired flow type.  We found that a flow rate of at least 12 mL/min for the hexane 
phase yields desirable conditions for the formation of solid without channel blockage, 
although a rate as low as 5 mL/min acts as an efficient purging system by keeping the 
channel walls free of solids.   
The final microfluidic reaction we studied was the conversion of 4-
chlorobenzoyl chloride (7) and methylamine (8) into 4-chloro-N-methylbenzamide (9; 










7 8 9  
Scheme 1.3.  Synthesis of 4-chloro-N-methylbenzamide (9). 
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This highly exothermic reaction was performed in our microreactor with no safety 
concerns.  The small dimensions of the device not only mitigated the violence with 
which the reaction took place, but they have also increased the yield of 9 (Table 1.1).  
The use of toluene as the carrier phase for this reaction further demonstrates the 
versatility of our system.   
Batch syntheses were carried out as a control by stirring the reagents for the 
same amount of time as the microreactor experiments were allowed to run.  As 
indicated in Table 1.1, the yields for the microreactor products are comparable to—if 
not greater than—those for the batch reactions. Also, space–time yields (STY) for the 
solids formed by microscale flow were much higher than those for solids formed in 
the macroscale batch reactions.  High yields were obtained in the microfluidic system 
even when one reagent was miscible with the carrier phase.  Although we expected 
lower yields as a result of the miscible reactant flowing into both the carrier and 
reactant phases, this was not observed, which suggests that diffusion is fast enough in 
our system to ensure reagent mixing. 
 
Table 1.1.  Synthesis of solids in our microfluidic device. 
Product System Yield (%)a Purity (%)b STYc STY rel 
6 flow 97.0 94.5 11.44 25.55 
6 batch 99.4 96.6 0.4478 1.00 
9 flow 87.6 > 99 9.150 20.43 
9 batch 76.9 > 99 0.7140 1.59 
aCrude yields are reported for 6, purified yields are reported for 9. 
bPurities were determined from 13C satellites from 1H NMR spectra. Purities of the 
crude product are reported for 6, purities of the purified product are reported for 9. 
cSpace-time yields are reported in mol/m3•min. 
 
Conclusion 
In summary, we have reported a practical method for producing solids in 
microreactors. As demonstrated by the indigo synthesis, by performing these reactions 
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in a monodisperse droplet flow, the solid particles are effectively isolated from the 
walls of the tubing.  Our device not only allows the practical synthesis of solids in 
microfluidic devices, it also retains the advantages of traditional microreactors.  Its 
ease of use, the widespread availability of many of its components, and its versatility 
provide further benefits.  Future work with our microfluidic device includes 
temperature-controlled experiments as well as multistep syntheses in a single device. 
 
Afterword 
 From the interfacial polymerization performed by Elizabeth Quevedo and 
Jeremy Steinbacher to the work discussed here to the packed-bed microreactors 
developed by Andrew Bogdan, the McQuade group has shown that practical, 
affordable microreactors can be assembled from common laboratory equipment.  This 
first instance of organic synthesis in our lab was a success, and it set the stage for the 




All materials were used as received unless otherwise noted.  4-Chlorobenzoyl 
chloride was recrystallized from EtOH prior to use.  1H NMR and 13C NMR spectra 
were recorded on Varian Mercury 300 MHz and Inova 400 MHz spectrometers 
operating at 299.763 MHz and 399.780 MHz, respectively, using residual solvent as 
the reference.  Data are reported as s = singlet, d = doublet, bd = broad doublet.  
Microfluidic reactors consisted of Harvard Apparatus Standard Pump 22 syringe 
pumps, Hamilton syringes, 30-gauge blunt-edge needles, and 0.0625 inch (1.59 mm) 
internal diameter (i.d.) PVC or 0.066 inch (1.68 mm) i.d. polyethylene (PE) tubing. 
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Indigo (3): Mineral oil (15 mL, 3 mL/min) was used as the carrier phase in 0.0625 
inch (1.59 mm) internal diameter (i.d.) PVC tubing. NaOH (1m in water, 3 mL, 0.6 
mL/min) was injected into the center of the carrier phase.  2 (0.66m in acetone (1), 3 
mL, 0.6 mL/min) was introduced into the tubing further downstream.  The pumps 
were allowed to run for 5 minutes while the product was collected over an ice–water 
bath.  
 
N,N’-Dicyclohexylethylenediimine (6): Hexane (mixture of isomers, 60 mL, 6 
mL/min) was used as the carrier phase in 0.066 inch (1.68 mm) i.d. polyethylene (PE) 
tubing.  glyoxal (4, 0.40 M in water, 12 mL, 1.2 mL/min) was injected into the center 
of the carrier phase.  Cyclohexylamine (5, 4.368 M in water, 2.4 mL, 0.24 mL/min) 
was introduced into the tubing further downstream.  The pumps were allowed to run 
for 10 minutes while the product was collected at room temperature.  Evaporation of 
the solvent yielded a white solid: 1H NMR (400 MHz, d6-DMSO) δ 8.48 (bd, 1H), 
7.80 (d, 2H), 7.43 (d, 2H), 2.75 (d, 3H); 13C NMR (75 MHz, d6-DMSO) δ 166.2, 
136.6, 133.9, 129.6, 129.0, 26.9. 
 
4-Chloro-N-methylbenzamide (9): Toluene (70 mL, 7 mL/min) was used as the 
carrier phase in 0.066 inch (1.68 mm) i.d. PE tubing.  Methylamine (8, 1.44 M in 
water, 3 mL, 0.3 mL/min) was injected into the center of the carrier phase. 4-
Chlorobenzoyl chloride (7, 1.0 mL, 0.1 mL/min) was introduced into the tubing 
further downstream.  The pumps were allowed to run for 10 minutes while the product 
was collected at room temperature. Evaporation of the solvent and recrystallization 
from MeOH/H2O afforded needles of white solid: 1H NMR (300 MHz, CDCl3) δ 7.91 
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Ibuprofen and Atropine Syntheses in Flow 
 
Preface* 
 In early 2007, my adviser’s startup company, Systanix, embarked on a joint 
project with Foster Miller, Inc.  Funded by the Defense Advanced Research Projects 
Agency (DARPA), the goal of this project was to design common pathways for three 
active pharmaceutical ingredients (APIs), verify two of these syntheses as traditional 
batch reactions, and ultimately to perform these reactions in flow.  Andrew Bogdan 
and I, along with Cornell undergraduate student Daniel Kubis, were hired as 
consultants for the project and spent the months of February through August refining 
these syntheses and putting them into flow.  Much progress was made over the course 
of the project, however, some of the reactions remain unoptimized or incomplete due 
to time restraints.  This chapter describes the syntheses of ibuprofen and atropine and 
discusses the progress we made toward performing the reactions in flow. 
 
Abstract 
 We have developed syntheses containing common reaction pathways for the 
APIs ibuprofen and atropine.  The design of these reaction routes resulted in the 
realization of a previously unknown iodine-mediated rearrangement in the synthesis of 
atropine.  We have achieved both of these syntheses in flow using homogeneous 
reaction conditions, and we discuss progress toward the use of packed-bed 
microreactors for these syntheses. 
 
                                                
* The author thanks Dr. Steven Broadwater, Andrew Bogdan, and Daniel Kubis for 
their contribution to this unpublished work. 
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Introduction 
 Pharmaceutical synthesis is currently one of the most materials- and waste-
intensive sectors of the chemical industry.1  Recent initiatives to promote more 
sustainable chemistry—such as the implementation of Green Chemistry awards—as 
well as the establishment of green chemistry-oriented academic journals and 
conferences indicate that this is a problem that requires attention.  While these 
approaches have been and continue to be successful in reducing the materials and 
waste associated with the chemical pathways, they do not address issues such as the 
packaging, transport and storage of reagents and products, all of which contribute to 
the waste associated with pharmaceutical synthesis.2  Funded by DARPA, the 
objective of this project was to design common pathways for the syntheses of different 
APIs in flow, with the ultimate goal being on-demand drug generation in a portable 
flow device.  The incorporation of common reagents and reactions into these syntheses 
would minimize the number and types of materials needed for purification.  In 
addition, the reactor design and reactions themselves would allow for the on-demand 
generation of API in an on-site flow reactor, eliminating the need for product 
packaging and storage.  The two APIs chosen for this project were ibuprofen (1) and 
atropine (2), a non-steroidal anti-inflammatory drug (NSAID) and an anticholinergic 
agent, respectively.  The BHC Company (now BASF Corporation) synthesis of 












ibuprofen (1)  

























Scheme 2.2.  Synthesis of atropine (2).  Tropine is the product of a Raney Ni/H2 
reduction of tropinone, which can be synthesized via the Robinson tropinone 
synthesis.6 
 
 At the beginning of the project, we created synthetic designs for ibuprofen and 
atropine that utilize a common set of reactions.  The reaction design shown in Scheme 
2.3 begins with a Friedel-Crafts hydroxyalkylation between either isobutylbenzene or 



























Scheme 2.3.  Proposed syntheses of ibuprofen and atropine. 
 
 Friedel-Crafts reactions similar to the one described above are known; 
however, they typically involve more activated substrates.8-10  This chapter discusses 
our attempts to achieve this as well as other Friedel-Crafts reactions.  Though the 
synthetic routes shown in Scheme 2.3 ultimately proved to be unsuccessful, we 
established two new routes containing overlapping chemistry and were able to 
partially or fully perform these syntheses in flow. 
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Results and Discussion 
Ibuprofen in Batch.  As discussed above, we envisioned a route beginning 
with the Friedel-Crafts hydroxyalkylation of isobutylbenzene with a pyruvate ester, 
followed by deoxygenation11 and hydrolysis.  The trifluoromethanesulfonic acid 
(TfOH)-catalyzed Friedel-Crafts hydroxyalkylation, based on a similar reaction 
between substituted aromatics and ethyl 3,3,3-trifluoropyruvate,12 was found to 
produce a dimer of ethyl pyruvate under a variety of conditions (Table 2.1, entries 1-
4).  A solid-supported TfOH catalyst yielded the same product.13  After these 
unsuccessful attempts, we screened a number of Lewis acid catalysts, each of which 
resulted in either the wrong product or no reaction at all (Table 2.1, entries 6-12). 
 Having had no success with the Friedel-Crafts hydroxyalkylation of 
isobutylbenzene, we examined Friedel-Crafts alkylations with a variety of 
electrophiles that would directly yield the ester of ibuprofen.  Although this would 
remove the shared step of the ibuprofen and atropine syntheses, it would result in a 
concise, two-step synthesis of ibuprofen.  Such alkylations involving methyl acrylate 
a, ethyl lactate b, and ethyl 2-bromopropionate c have been reported in the  
literature,14-16 but as with the ethyl pyruvate hydroxyalkylations, they generally 
involve more activated substrates.  Unfortunately, though a variety of conditions were 













Table 2.1. Reaction conditions screened for the Friedel-Crafts alkylation of 











Entry Catalyst Conditions Major product 







2 TfOH (20 mol%) CH2Cl2, reflux 














4 TfOH (20 mol%) CH2Cl2, 90 °C, overnight 














6 SnCl4 (1.2 eq) CH2Cl2,0 °C to rt, 3 h undetermineda 
7 AlCl3 (1.5 eq) CH2Cl2,rt, under N2 undetermined 
8 TiCl4 (1.5 eq) CH2Cl2,rt, under N2 no reaction 
9 BF3OEt2 (1 eq) neat, rt no reaction 
10 TiCl4 (1.3 eq) 
Al2O3 (1.2 eq) 
CH2Cl2, rt no reaction 
11 BF3OEt2 (1.3 eq) 
Al2O3 (1.2 eq) 
CH2Cl2,rt no reaction 
12 AlCl3 (1.3 eq) 
Al2O3 (1.2 eq) 
CH2Cl2,rt no reaction 











Table 2.2. Reaction conditions screened for the Friedel-Crafts alkylation of 











a b: X = OH
c: X = Br  
Entry Electrophile Catalyst Conditions Major product 
1 a AlCl3 (1.5 eq) CH2Cl2, rt, under N2 
 
2 a AlCl3 (1.5 eq) 
HCl (g) 
CH2Cl2, rt, under N2 
 
3 a AlCl3 (1.5 eq) 
HCl (aq) 
CH2Cl2, rt, under N2 no reaction 
4 a SnCl4 (1.5 eq) CH2Cl2, rt, under N2 no reaction 
5 a TiCl4 (1.5 eq) CH2Cl2, rt, under N2 no reaction 
6 a BF3OEt2 (1 eq) neat, rt no reaction 
7 a AlCl3 (1.3 eq) 
Al2O3 (1.2 eq) 
CH2Cl2, rt undetermined 
8 b H2SO4 (aq, 80%) 75 °C, overnight no reaction 
9 b AlCl3 (1.3 eq) 
Al2O3 (1.2 eq) 
CH2Cl2, rt no reaction 
10 b TfOH 80 °C, overnight 
sealed vial 
no reaction 
11 c AlCl3 (1.5 eq) solvent: CH2Cl2 
room temp 
 
12 c AlCl3 (1.3 eq) 








 Our next approach for the synthesis of ibuprofen involved the conversion of 
known batch reactions into flow reactions.  The synthesis we chose consisted of a 
Friedel-Crafts acylation of isobutylbenzene with propionyl chloride, an iodine-
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mediated rearrangement,17 and saponification (Scheme 2.4).  These reactions were 
















4 1  
Scheme 2.4.  Revised synthesis of ibuprofen.  a“Iodine” refers to either I2 or 
PhI(OAc)2.18 
 
Atropine in Batch.  Because the Friedel-Crafts hydroxyalkylation proposed as 
the common first step of the ibuprofen and atropine syntheses was unsuccessful, we 
instead envisioned a new route that incorporated the iodine-mediated rearrangement 
used in the synthesis of ibuprofen (Scheme 2.5).  Although this specific rearrangement 
is unprecedented, the success we had with the ibuprofen synthesis inspired us to 














Scheme 2.5.  Revised retrosynthesis of atropine. 
 
 The first step of this synthesis involved the formation of 3-methoxy-
propiophenone (5) or 3-ethoxypropiophenone (6) from 3-chloropropiophenone 
(Scheme 2.6).  This step proved to be more problematic than expected, as the 
elimination pathway was often dominant, resulting in the formation of phenyl vinyl 
ketone as a byproduct.  Subsequent polymerization of this material often provided an 
intractable reaction mixture.  It was found that the reaction proceeded with the 
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addition of an alcoholic solution of KOH at 0 °C as opposed to adding KOH directly 
to the reaction mixture.  By premixing the KOH and methanol or ethanol, the 
exotherm was controlled and resulted in more efficient temperature control of the 








5: R = Me
6: R = Et  
Scheme 2.6.  Substitution of 3-chloropropiophenone. 
 
 Our first attempts at the iodine-mediated rearrangement of 5 or 6 also presented 
us with some challenges (Scheme 2.7).  Treatment of 5 or 6 with CH(OCH3)3 and I2 
consistently yielded 3-methoxy-2-iodopropiophenone (7) rather than the desired 
product.  However, we found that the use of PhI(OAc)2 rather than I2 furnished the 
rearranged product methyl 3-methoxy-2-phenylpropanoate (8) in 71% yield.  In 
addition, it was discovered that this transformation could be carried out at room 
temperature, as opposed to the literature-reported 60 °C.  In the context of carrying out 
chemistry in the field, room temperature reactions are advantageous because of the 



















Scheme 2.7. Iodine- and iodoso-mediated rearrangement of 3-alkoxypropiophenone.  
 
 It should be noted that for both the I2- and PhI(OAc)2-mediated reactions, the 
respective products contained a methyl ether regardless of whether 5 or 6 was used as 
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the starting material.  Since the original methoxy or ethoxy groups were being 
replaced by a methoxy group from CH(OCH3)3 during the reaction, we saw the 
potential for performing the substitution and rearrangement of 3-chloropropiophenone 
in one step.  However, the attempted rearrangement 3-chloropropiophenone with 
either I2 or PhI(OAc)2 was unsuccessful. 
 With 8 in hand, we saw three approaches to the completion of the atropine 
synthesis. The first involved a transesterification of the methyl ester product of the 
iodine-mediated rearrangement (Scheme 2.8A).  Subsequent cleavage of the methyl 
ether would liberate the unprotected alcohol and result in the formation of atropine. 
The second route involves saponification of the methyl ester, followed by 
esterification with tropine (Scheme 2.8B).  Finally, the route described in Scheme 
2.8C involves saponification followed by activation of the resulting carboxylic acid to 
facilitate ester formation with tropine.  
 Though a variety of conditions for transesterification (Scheme 2.8A) were 
screened, none were successful.  For the direct esterification route (Scheme 2.8B), 
saponification of the methyl ester of 8 with methanolic KOH was achieved to provide 
the desired product 9 in 88% yield, but none of the esterification conditions we 
employed effected the coupling of 9 with tropine.  However, the carboxylic acid 9 
could be activated using thionyl chloride to produce an acid chloride (Scheme 2.8C).  
After removing excess thionyl chloride by distillation, the acid chloride was coupled 


























Scheme 2.8.  Alternative routes for the synthesis of atropine from 8 and tropine: A) 
transesterification; B) esterification; C) esterification using an activated carboxylic 
acid. 
 
 The final step of the atropine synthesis involved a boron tribromide-mediated 
demethylation.  Analysis of this reaction using thin layer chromatography indicated 
that atropine was being formed under these conditions, however no isolated yield was 
obtained.  It is possible that the tertiary amine in the tropine moiety was slowly being 
methylated by the methyl bromide byproduct that is formed during the course of the 
reaction.  This method is very promising and might be optimized (reaction time and 



















10 2  
Scheme 2.9.  Saponification of 8, followed by esterification using an activated 
carboxylic acid. 
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Ibuprofen in Flow.  Once the successful syntheses of ibuprofen and atropine 
were achieved, the next objective of this project was to find conditions that allowed 
the reactions to be run in flow.  The majority of this development was performed by 
Andrew Bogdan and Daniel Kubis and will not be discussed in detail here.  Instead, 
the optimized conditions and results for the synthesis of ibuprofen are shown below 
(Schemes 2.10-2.12).  Typical reactor setup consisted of two syringe pumps that 
flowed reagents together inside poly(vinyl chloride) (PVC) tubing (Figure 2.1).  

















Scheme 2.10. Optimization of Friedel-Crafts acylation in flow.  Pump 1: 
isobutylbenzene, CH2Cl2, 30 µL/min; pump 2: propionyl chloride, AlCl3, CH2Cl2, 30 











Scheme 2.11. Optimization of PhI(OAc)2-catalyzed rearrangement in flow.  Pump 1: 
4’-isobutylpropiophenone, PhI(OAc)2, CH(OCH3)3, CH2Cl2, 45 µL/min; pump 2: 













Scheme 2.12.  Optimization of saponification in flow.  Pump 1: methyl 2-(4’-
isobutylphenyl)propanoate, MeOH, 25 µL/min; pump 2: KOH, MeOH, 25 µL/min; 
room temperature. aUnoptimized yield. 
 
 In addition to identifying appropriate flow conditions for the homogeneous 
reactions discussed above, we also looked into developing solid-supported catalysts 
and reagents for these transformations.  Packed-bed microreactors combine the 
benefits of heterogeneous catalysts (ease of removal from the reaction mixture, 
catalyst recycling, etc…) with the high heat transfer and mixing associated with 
microreactors, making them an attractive option. 
 The first reaction that we investigated is the iodine-mediated oxidative 
rearrangement used in both the ibuprofen and atropine syntheses.  As an alternative to 
using PhI(OAc)2 for the rearrangement, we envisioned supporting the iodoso reagent 
to create a packed-bed microreactor in which the reagent can be regenerated and 
recycled.19  Such a reagent could also enable multistep synthesis, as it would remain 
site-isolated from the components of other reactions.  Others in the McQuade group 
have previously demonstrated that the performance of packed-bed microreactors is 
highly dependent on the solid support.20  We therefore screened a variety of 
heterogeneous materials in our development of a solid-supported iodoso reagent. 
 The McQuade group has reported several examples of creating heterogeneous 
catalysts using Rohm and Haas’s Amberzyme Oxirane (AO) as a starting material.20,21  
AO is an excellent support for continuous flow applications because it is highly 
solvent-tolerant and does not exhibit variable swelling behavior, therefore providing 
predictable flow behavior.  Utilizing a published methodology, a solid-supported 


















Scheme 2.13.  Resin functionalization via Huisgen reaction. 
 
 In addition, we functionalized several amine-containing resins using standard 
peptide coupling procedures.22  These resins included aminomethyl polystyrene, 
JandaJel (polystyrene core functionalized with poly(ethylene glycol) chains), and an 
amine version of AO.  A third approach to preparing a heterogeneous iodobenzene 
reagent involved the direct iodination of unfunctionalized polystyrene resin (2% DVB) 
using I2, I2O5, CCl4, H2SO4, and nitrobenzene.23,24 
Once prepared, each supported iodobenzene reagent was oxidized with 
peracetic acid to provide heterogeneous iodoso reagents.  The prepared resins were 
analyzed for iodine content by elemental analysis and screened for activity.  These 
reactions were carried out in batch due to the ability to set up several small-scale 
reactions that do not consume significant amounts of resin.  It can be seen in Table 2.3 
that several of the resins demonstrated activity and the AO amide was recycled 
successfully. 
 
Table 2.3.  Results of 4’-isobutylpropiophenone rearrangement performed in batch 








Resin Loading (mmol/g)a Activity Recyclable 
AO (Huisgen) 0.14 Yes No 
PS (amide) 1.0 Yes No 
JandaJel Not determined No No 
AO (amide) 0.56-0.68 Yes Yes 
PS (iodinated) 0.7 Yes No 
aDetermined by elemental analysis. 
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 Once we identified the AO amide resin as a functional supported reagent that 
could be successfully recycled, we attempted to use it in a packed-bed microreactor.  
The general reactor setup is shown in Figure 2.2.  Because the reaction required a 
temperature of 60 °C, temperature control was achieved by housing the packed-bed 
segment of the reactor inside of an HPLC column heater.  However, instead of flowing 
the reagents together directly inside the column heater, we found that it was necessary 
first to cool the reagents in an ice water bath to minimize gas generation due to heat 
formation when the fluid streams are mixed.  
 
 
Figure 2.2. Representation of general reactor setup for rearrangement of 4-
isobutylpropiophenone mediated by supported iodoso compound.  Pump 1: 
CH(OCH3)3, 4’-isobutylpropiophenone; pump 2: H2SO4. 
 
 Despite the success we had with the AO amine resin in batch mode, we were 
unable to produce any of the rearranged product 4 in flow.  Although we were 
achieving moderate to high conversions of the starting material 3, we did not see any 
evidence that 4 was being formed.  When we later attempted to optimize the reaction 
in batch, we found that the reactions were no longer producing 4, rather they were 
forming the same unknown byproduct that we saw in the flow reactions.  This 
observation suggests that there was a problem with our reagents or resin, not with the 
transition to flow mode.  Although this project was over before we could solve these 
problems our preliminary work suggests that this might be a viable reaction once the 
problem is identified and the appropriate flow conditions are chosen. 
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Atropine in Flow.  Attempts to put the atropine synthesis in flow were also 
met with success.  Again, since the majority of this work was performed by Andrew 
Bogdan and Daniel Kubis, it will not be discussed in detail.  The synthesis of 5 was 
carried out using our microreactor to provide the desired product in 98% yield.  In 
addition, this transformation was carried out at room temperature.  This obviates the 
need to cool the reaction, which is necessary in batch mode.  The optimized conditions 












Scheme 2.14.  Optimization of ether synthesis in flow.  Pump 1: 3-chloro-
propiophenone (0.2 M in MeOH), 65 µL/min; pump 2: KOH (0.3 M in MeOH), 65 
µL/min; room temperature. 
 
 The rearrangement of 3-methoxypropiophenone was successfully performed 
using our microreactor.  Although a high yield of 97% was achieved, this reaction was 
not optimized to determine what the minimal equivalents of reagents are necessary 
(Scheme 2.15).  Given the success with the iodine-mediated rearrangement in the 












1 eq  
Scheme 2.15.  Unoptimized rearrangement of 5 in flow.  Pump 1: 5, PhI(OAc)2, 
CH(OCH3)3, CH2Cl2, 130 µL/min; pump 2: H2SO4, 2.45 µL/min; room temperature. 
 
 Like the saponification of 4 in flow for the ibuprofen synthesis, similar treatment 
of 8 with methanolic KOH in flow successfully produced 9 in an unoptimized 74% 
yield.  In order to develop appropriate flow reaction conditions for performing the 
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thionyl chloride mediated ester synthesis, we opted to use phenylacetic acid and 
methanol as test substrates to avoid sacrificing valuable starting material (Scheme 
2.16).  Using only one equivalent of thionyl chloride, the acid chloride was generated 
and subsequently quenched into methanol to provide the desired methyl ester 12 in 







OSOCl2  (1 eq)
1 eq 12  
Scheme 2.16.  Esterification of phenylacetic acid in flow. 
 
 Applying the conditions developed above, 9 was activated with thionyl chloride 
and quenched into a solution of tropine in toluene at 80 °C (Scheme 2.17).  Following 
isolation, the desired product was obtained in a 30% yield.  It is possible that the 
conditions for the reaction shown in Scheme 2.16 do not directly translate to these 
substrates.  In any case, this reaction was performed successfully and further 
optimization of the reaction conditions would undoubtedly result in an increase in 
yield.  It should be noted that the continuous flow conditions do not require excess 
thionyl chloride, and therefore removes the need for an intermediate distillation step. 
 














Scheme 2.17.  Esterification of 9. 
 
 The final step of the atropine synthesis in flow—cleavage of the methyl ether—
was not attempted due to the time constraints that left the batch process unoptimized.  
However, the preliminary results for this transformation in batch are promising, and 




 Reaction Metrics.  As chemists have become more aware of the need to create 
more environmentally friendly reactions, a variety of metrics for determining the 
greenness of reactions and processes have been developed.  The reaction metrics for 
ibuprofen and atropine have been determined as much as possible with the current 
state of each synthesis.  It is necessary to give three brief definitions of the 
abbreviations that are used in this discussion:25-32 
 
• Atom Economy (AE): Describes how much of the reactants remain in the final 
product.  This does not account for stoichiometry or solvent; higher atom  
 economy values represent more efficient processes.  
 
• E-Factor: This describes the mass of waste generated per mass of product  
obtained; lower E-factor values represent more efficient processes. 
 
• Reaction Mass Efficiency (RME): This is the percentage of the mass of 
reactants that remain in the final product and does account for solvent and 
stoichiometry; higher RME values represent more efficient processes.  
 
 For the purposes of this discussion, work-up conditions were not included and 
therefore the actual E-factors will be larger and the actual RME values will be lower.  
An interesting point to make about the values listed in Table 2.4 is that the E-factors 
for the overall ibuprofen and atropine syntheses is roughly 3- and 2-fold less for the 
flow synthesis in comparison to batch, respectively, which indicates the increase in 
chemical efficiency achieved by using microreactors.  
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Table 2.4.  Reaction metrics for the syntheses of ibuprofen and atropine. 
 Atom economy E-factor RME 
Ibuprofen (batch) 0.19 25.4 0.04 
Ibuprofen (flow) 0.19 8.3 0.11 
Atropine (batch)a 0.20 37.2 0.03 
Atropine (flow)a 0.20 15.9 0.06 
aE-factor and RME for atropine syntheses were calculated for the first three steps. 
 
Conclusion 
 We have successfully designed and performed syntheses of ibuprofen and 
atropine that contain similar reaction pathways.  Through our attempts to utilize 
similar chemical reactions in the two syntheses, we developed a previously unreported 
route to atropine that employs a hypervalent iodine-mediated rearrangement.  Both 
syntheses were validated in batch, and significant progress was made toward 
performing them in flow.  Given more time, we expect that the syntheses for ibuprofen 
and atropine can be performed entirely in flow, with minimization of solvent volumes 
and excess reagents. 
 
Afterword 
 From our perspective, the DARPA project was a success.  Though we were not 
able to isolate and characterize atropine, we prepared the methyl ester, and there is 
evidence that it was successfully converted to atropine.  Further work on this project 
may be carried out in the McQuade lab, including optimization of the atropine 
synthesis, and the incorporation of in-line work-up steps so that synthesis and 







All reagents were used without purification unless otherwise noted.  
Microfluidic reactor components included Harvard Apparatus Standard Pump 22 
syringe pumps and 0.0625 inch (1.59 mm) internal diameter (i.d.) poly(vinyl chloride) 
(PVC) tubing.  For iodine elemental analysis, functionalized resins were sent to 
Robertson Microlit Laboratories for analysis (www.robertson-microlit.com).  Gas 
chromatographic (GC) analyses were performed using a Varian CP-3800 GC equipped 
with a Varian CP-8400 autosampler, a flame ionization detector (FID) and a Varian 
CP-Sil 5CB column (length = 15 m, inner diameter = 0.25 mm, and film thickness = 
0.25 µm. The temperature program for GC analysis held the temperature constant at 
80 ºC, heated samples from 80 to 200 ºC at 17 ºC/min, and held at 200 ºC for 2 min. 
Inlet and detector temperatures were set constant at 220 and 250 ºC, respectively. 
Mesitylene was used as an internal standard to calculate reaction conversion.  1H 
NMR and 13C NMR spectra were recorded on Varian Mercury 300 MHz and Inova 
400 MHz spectrometers operating at 299.763 MHz and 399.780 MHz, respectively, 
using residual solvent as the reference..  Data are reported as s = singlet, d = doublet, t 
= triplet, q = quadruplet, m = multiplet. 
 
4’-Isobutylpropiophenone (3).  Propionyl chloride (2.17 mL, 25 mmol) was added 
dropwise to a mixture of isobutylbenzene (3.95 mL, 25 mmol), AlCl3 (5 g, 37.5 mmol) 
and CH2Cl2 (200 mL) and stirred at room temperature for 5 hours.  The reaction was 
quenched with cold HCl (1 M, 100 mL) and the product was extracted with CH2Cl2 (3 
x 100 mL).  The combined organic layers were dried over Na2SO4 and concentrated.  
The product was distilled under vacuum (0.3 Torr, 78-80 °C) to produce 4’-
isobutylpropiophenone as a colorless oil (4.06 g, 85% yield): 1H NMR (400 MHz, 
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CDCl3): δ 7.83 (d, 2H), 7.19 (d, 2H), 2.95 (q, 2H), 2.50 (d, 2H), 1.87 (m, 1H), 1.20 (t, 
3H), 0.85 (d, 6H); 13C NMR (100 MHz, CDCl3): δ 200.6, 147.4, 134.9, 129.4, 128.1, 
45.5, 31.8, 31.7, 30.3, 22.5, 8.5. 
 
Methyl 2-(4-isobutylphenyl)propanoate (4).  Method A: Iodine (2.5 g, 10 mmol) 
was added at once to a solution of 4’-isobutylpropiophenone (0.95 g, 5 mmol) in 
trimethyl orthoformate (2.73 mL, 25 mmol) and stirred at room temperature for 16 
hours.  The reaction was poured into 10% Na2S2O3 (50 mL) and the product was 
extracted with CHCl3 (3 x 50 mL). The combined organic layers were dried over 
Na2SO4 and concentrated.  The product was purified using column chromatography 
(silica, 9:1 hexanes:EtOAc) to produce methyl 2-(4-isobutylphenyl)propanoate as a 
colorless oil (0.95 g, 86% yield).  
Method B: Prepared from the general method of Tamura et al.18  4’-isobutyl-
propiophenone (38 mg, 0.2 mmol), (diacetoxy)iodobenzene (77 mg, 0.24 mmol), 
trimethyl orthoformate  (0.6 mL, 5.5 mmol), and H2SO4 (98%, 21.3 µL) were stirred at 
60 °C for 10 min.  The reaction was quenched with H2O (2 mL) and the product was 
extracted with ether.  GC analysis indicated complete conversion to methyl 2-(4-
isobutylphenyl)propanoate: 1H NMR (400 MHz, CDCl3): δ 7.22 (d, 2H), 7.13 (d, 2H), 
3.72 (q, 1H), 3.61 (s, 3H), 2.44 (d, 2H), 1.86 (m, 1H), 1.50 (d, 3H), 0.90 (d, 6H); 13C 
NMR (100 MHz, CDCl3): δ 175.4, 140.8, 138.0, 129.6, 127.4, 52.1, 45.3, 45.2, 30.4, 
22.6, 18.9. 
 
2-(4-Isobutylphenyl)propanoic acid (1, ibuprofen). Methyl 2-(4-
isobutylphenyl)propanoate (0.33 g, 1.5 mmol) and 15% KOH in MeOH (5.3 mL) were 
stirred at room temperature for 16 hours.  The reaction was acidified with 5 M HCl, 
extracted with EtOAc (3 x 20 mL), washed with brine (20 mL), dried over Na2SO4, 
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and concentrated in vacuo to afford ibuprofen as a white solid (309 mg, quant):  1H 
NMR (300 MHz, CDCl3): δ 7.24 (d, 2H), 7.16 (d, 2H), 3.78 (q, 1H), 2.49 (d, 2H), 1.89 
(m, 1H), 1.51 (d, 3H), 0.91 (d, 6H); 13C NMR (75 MHz, CDCl3): δ 181.4, 141.1, 
137.2, 129.6, 127.5, 45.3, 45.2, 30.4, 22.6, 18.3. 
 
3-Methoxypropiophenone (5).  KOH (1.23 g, 21.9 mmol) and MeOH (50 mL) were 
stirred at room temperature fully dissolved and then cooled to 0 °C.  3-Chloro-
propiophenone (2.5 g, 14.8 mmol) was added and the reaction was stirred at 0 °C for 
1.25 h.  H2O (25 mL) was added and the product was extracted with CH2Cl2 (3 x 25 
mL), washed with brine (20 mL), dried over Na2SO4 and concentrated in vacuo. The 
product was purified using column chromatography (silica, 9:1 hexanes:EtOAc) to 
give 3-methoxypropiophenone as a light yellow oil (2.39 g, 98% yield): 1H NMR (300 
MHz, CDCl3): δ 8.00 (d, 2H), 7.58 (t, 1H), 7.49 (t, 2H), 3.92 (t, 2H), 3.41 (s, 3H), 3.24 
(t, 2H). 
 
3-Ethoxypropiophenone (6).  KOH (2.62 g, 46.7 mmol) and EtOH (150 mL) were 
stirred at room temperature until the KOH fully dissolved and then cooled to 0 °C.  3-
Chloropropiophenone (5.31g, 31.5 mmol) was added and the reaction was stirred at 0 
°C for 1.25 h.  H2O (75 mL) was added and the product was extracted with CH2Cl2 (3 
x 75 mL), washed with brine (50 mL), dried over Na2SO4 and concentrated in vacuo.  
The product was purified using column chromatography (silica, 9:1 hexanes:EtOAc) 
to give 3-ethoxypropiophenone as a light yellow oil (4.47 g, 80% yield): 1H NMR 
(300 MHz, CDCl3): δ 7.98 (d, 2H), 7.57 (t, 1H), 7.49 (t, 2H), 3.90 (t, 2H), 3.54 (q, 
2H), 3.28 (t, 2H), 1.20 (t, 3H). 
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3-Methoxy-2-iodopropiophenone (7).  3-Ethoxypropiophenone (356.5 mg, 2 mmol), 
CH(OCH3)3 (1.1 mL, 10 mmol), and I2 (1.015 g, 4 mmol) were stirred at room 
temperature for 16 h.  The reaction was poured into 10% Na2S2O3 (20 mL) and the 
product was extracted with CHCl3 (3 x 25 mL), dried over Na2SO4, and concentrated 
in vacuo.  The product was purified using column chromatography (silica, 9:1 
hexanes:EtOAc) to give 3-methoxy-2-iodopropiophenone: 1H NMR (300 MHz, 
CDCl3): δ 8.02 (d, 2H), 7.60 (t, 1H), 7.51 (t, 2H), 5.42 (dd 1H), 4.10 (dd, 1H), 3.89 
(dd, 1H), 3.42 (s, 1H); 13C NMR (75 MHz, CDCl3): δ193.8, 134.3, 134.0, 129.0, 
128.9, 74.1, 59.5, 21.1. 
 
Methyl 3-methoxy-2-phenylpropanoate (8).  H2SO4 (98%, 3 mL) was added to a 
mixture of 3-methoxypropiophenone (4.58 g, 27.9 mmol), CH(OCH3)3 (83.8 mL, 766 
mmol), and PhI(OAc)2 (10.78 g, 33.5 mmol) and the reaction was stirred at room 
temperature for 2.5 h.  The reaction was quenched with H2O (30 mL), extracted with 
Et2O (3 x 50 mL), dried over Na2SO4, and concentrated.  The iodobenzene that was 
produced was removed by vacuum distillation, and the product was purified by 
column chromatography (silica, 9:1 hexanes:EtOAc) to give methyl 3-methoxy-2-
phenylpropanoate (3.85 g, 71% yield): 1H NMR (300 MHz, CDCl3): δ 7.40 (m, 5H), 
4.02 (dd, 1H), 3.93 (dd, 1H), 3.77 (s, 3H), 3.61 (dd, 1H), 3.42 (s, 3H); 13C NMR (75 
MHz, CDCl3) δ 173.1, 135.9, 129.0, 128.3, 128.0, 74.5, 59.3, 52.4, 52.1. 
 
3-Methoxy-2-phenylpropanoic acid (9).  Methyl 3-methoxy-2-phenylpropanoate (8, 
3.85 g, 0.2 mmol) and KOH (15% in MeOH, 72 mL) were stirred at room temperature 
for 16 h.  The reaction was diluted with water and washed with Et2O.  The aqueous 
layer was acidified with 5M HCl and the product was extracted with EtOAc (3 x 25 
mL), dried over Na2SO4, and concentrated in vacuo to give 3-Methoxy-2-
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phenylpropanoic acid (3.13, 88% yield): 1H NMR (CDCl3, 300 MHz): δ 7.35 (m, 5H), 
3.97 (m, 2H), 3.64 (dd, 1H), 3.40 (s, 3H). 
 
Atropine methyl ether (10). 3-Methoxy-2-phenylpropanoyl chloride (200 mg, 1.0 
mmol) was dissolved in toluene (10 mL) and heated to 80 °C.  Tropine (149 mg, 1.1 
mmol) was added and the reaction was stirred for 4 h, during which a white solid 
precipitated.  The solid was removed by filtration and dried under vacuum. 13C NMR 
(CDCl3, 75 MHz): δ: 171.6, 136.0, 129.0, 128.2, 127.9, 74.0, 68.0, 60.0, 59.9, 59.2, 
52.6, 40.4, 36.4, 36.3, 25.5, 25.2. 
 
4-Iodo-N-(prop-2-ynyl)benzamide (11).  Propargylamine (0.28 mL, 4.8 mmol) and 
triethylamine (1.24 mL, 8.8 mmol) were added to a solution of 4-iodobenzoic acid 
(992 mg, 8 mmol), EDC•HCl (800 mg, 4.4 mmol), and HOBt (660 mg, 4.8 mmol) in 
DMF (20 mL).  The reaction was stirred at room temperature for 16 h.  The reaction 
was quenched with saturated NH4Cl (20 mL) and the solvent was distilled off under 
vacuum.  The product was dissolved in CH2Cl2 (30 mL) and washed with 10% citric 
acid (30 mL), H2O (25 mL), NaHCO3 (25 mL), and brine (25 mL).  The organic layer 
was dried over Na2SO4 and concentrated in vacuo to give a white solid (0.98 g, 86% 
crude yield).  The product was recrystallized from hexanes/EtOAc to give 4-iodo-N-
(prop-2-ynyl)benzamide as white crystals (752 mg, 66% yield): 1H NMR (CDCl3, 300 
MHz): δ 7.91 (d, 2H), 7.52 (d, 2H), 6.22 (bs, 1H), 4.24 (s, 2H), 2.30 (s, 1H); 13C NMR 
(CD3OD, 75 MHz): δ 159.8, 137.8, 133.9, 128.9, 98.9, 79.7, 71.2, 29.0. 
 
Methyl 2-phenylethanoate (12).  1H NMR (CDCl3, 300 MHz): δ 7.38 (m, 5H), 3.77 
(s, 3H), 3.64 (s, 2H). 
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Preparation of Amberzyme Oxirane Azide Resin.  Amberzyme Oxirane resin 
(5.09) was stirred with NaN3 (2.65 g, 40.8 mmol), NH4Cl (1.15 g, 21.5 mmol) in 
MeOH/H2O (9:1, 250 mL) at reflux for 16 h.  The resin was filtered off over a glass 
frit, washed with H2O, MeOH, and Et2O, and dried under vacuum to give Amberzyme 
Oxirane azide resin (5.38 g). 
 
Preparation of Amberzyme Oxirane Amine Resin.  Amberzyme Oxirane azide 
resin (1.15 g), triphenylphosphine (1.5 g, 5.7 mmol) and THF (46 mL) were stirred 
gently at reflux for 6 h.  H2O (25 mL) was added and the reaction was stirred at room 
temperature for 1 h.  The resin was washed with H2O, MeOH, and CH2Cl2, and dried 
under vacuum to give Amberzyme Oxirane amine resin (1.05 g). 
 
Iodination of Polystyrene Resin. Prepared according to the method of Huang et 
al.22,23  Polystyrene (2% cross-linked, 2 g), I2 (2 g, __ mmol), I2O5 (0.8 g, __mmol), 
CCl4 (0.8 mL), H2SO4 (50%, 8 mL), and nitrosobenzene (24 mL) were stirred at 100 
°C for 3 days.  The resin was filtered off over a glass frit, washed with Et2O, acetone, 
and CH2Cl2 and dried under vacuum to give iodinated polystyrene (2.05 g). 
 
Functionalization of Amberzyme Oxirane Azide Resin.  4-Iodo-N-(prop-2-
ynyl)benzamide, (0.49 g, 1.72 mmol) Amberzyme Oxirane azide resin (1.15 g), CuI 
(21.8 mg, 0.11 mmol), and THF (46 mL) were placed in a round bottom flask and 
mixed on a rotary evaporator motor under an atmosphere of N2 for 3 days.  The resin 
was filtered off over a glass frit, washed with THF, MeOH, and CH2Cl2, followed by 
HCl (1M), H2O, NaHCO3, and MeOH, and dried under vacuum to give the 
functionalized resin (1.23 g). 
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General Procedure for Functionalization of Amine Resins. 4-Iodobenzoic acid 
(496 mg, 2 mmol), HOBt (326 mg, 2.1 mmol), DIC (311.6 µL, 2 mmol), DMF, and 
the appropriate amount of resin were mixed on a rotary evaporator motor at room 
temperature for 2 days.  Pyridine (40.3 µL) and acetic anhydride (47.3 µL) were added 
to acylate the remaining free amines and the reaction continued to mix for 3 h.  The 
resin was filtered off over a glass frit, washed with DMF and MeOH, and dried under 
vacuum. 
 
Aminomethyl polystyrene: Prepared according to the general procedure with 
0.67 mg resin (~1.5 mmol/g, prepared by Brian P. Mason) and 10 mL DMF. 
 
Aminomethyl JandaJel: Prepared according to the general procedure with 1.0 g 
resin (100-200 mesh, 2% cross-linked, 1 mmol/g) and 20 mL DMF. 
 
Amberzyme Oxirane Amine: Prepared according to the general procedure with 
0.8 g resin (~1.25 mmol/g) and 10 mL DMF. 
 
Oxidation of Supported Iodobenzenes.  The resins were oxidized with peracetic acid 
(10 mL per 1.25 g resin) at 40 °C for 16 h.  The resins were filtered off over a glass 
frit and dried under vacuum.  Final reagent loading was determined by iodine 
elemental analysis. 
 
Preparation of Peracetic Acid.  Prepared according to the method of Ficht et al.21  
Acetic anhydride (20 mL) and H2O2 (30%, 5.83 mL) were mixed at 0 °C for 4 h.  
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General Procedure for Rearrangement of 4’-Isobutylpropiophenone Using 
Supported Iodoso Reagents.  4’-Isobutylpropiophenone (31.5 mg, 0.17 mmol), 
CH(OCH3)3 (3 mL, 27.4 mmol), and the supported iodoso reagent (0.2 mmol, 
determined by elemental analysis) were cooled to 0 °C.  H2SO4 was added and the 
reaction was mixed at 60 °C for 2 h.  The reaction was quenched with H2) and the 
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Microcapsule Enabled Multicatalyst System 
 
Preface 
 When I joined the McQuade group in 2004, they had developed the techniques 
to microencapsulate catalysts, but had not yet incorporated them into multicatalyst 
systems.  One of the first projects given to me by my adviser was to synthesize the 
drug pregabalin.  Though pregabalin itself is not a very complicated target, the 
challenge was that the synthesis needed to feature a multicatalyst system.  Muris 
Kobašlija had been doing some unrelated work with encapsulated polyamines.  These 
microcapsules turned out to be a catalyst for the first step of pregabalin synthesis.  
Paired with a nickel-based catalyst for the second step, these two catalysts worked in 
tandem to produce a precursor to pregabalin, and the McQuade group’s first 
multicatalyst system was born. 
 
Abstract* 
We present a new microencapsulated catalyst and report its use in a tandem 
multicatalyst reaction.  Using an encapsulation technique, we developed an active, 
site-isolated amine catalyst that is capable of catalyzing the addition of nitromethane 
to an aldehyde.  When a second Lewis acid catalyst is added, the nitroalkene 
intermediate is trapped and converted to the corresponding Michael adduct.  We show 
that if the amine catalyst is not encapsulated, the two catalysts cannot function 
together to produce the desired product.  Moreover, if the two reactions are performed 
                                                
* Reproduced in part with permission from: Poe, S. L.; Kobašlija, M.; McQuade, D. T. 
J. Am. Chem. Soc. 2006, 128, 15586. Copyright 2006 American Chemical Society. 
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in sequence rather than in tandem, the first reaction results in an undesired dinitro 
product and the desired Michael adduct is not formed. 
 
Introduction 
One-pot multistep reactions are effective at reducing the waste and cost of a 
synthetic route because they decrease the number of work-ups and purifications, as 
well as the volume of solvent used.1-3  These reactions are especially useful when 
multiple catalysts are used so that one traps an unstable intermediate formed by the 
other.  Though a variety of these reactions have been reported, they are limited to a 
relatively small number of systems where the catalysts are compatible with each 
other.1,4,5  The work of Patchornik in 1981 demonstrated that this limitation can be 
overcome by immobilizing incompatible catalysts on solid supports.6  Though this 
strategy has since been used to prevent catalyst interactions,7 it often results in the loss 
of catalytic activity and in effect lowers efficiency.8,9  Recently, one-pot multicatalyst 
reactions have been facilitated by site-isolated catalysts that diverge from the 
traditional solid support paradigm.10-16  These examples show how materials such as 
sol-gels and star-polymers render incompatible catalysts compatible.  However, the 
reactions featured are relatively simple and yield the same result when run stepwise.  
In addition, such successful examples are few and not easily generalized for new 
catalysts. It is therefore desirable to develop other techniques to site-isolate catalysts 
for use in one-pot multicatalyst reactions. 
We recently reported the successful encapsulation of a polymeric catalyst via 
interfacial polymerization of an oil-in-water emulsion.17,18  We demonstrated that 
because of the unique microenvironment created by our isolation technique, our 
catalyst showed greater catalytic activity than a comparable solid-supported catalyst.  
Herein, we extend the scope of our technique by reporting a microencapsulated amine 
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catalyst and demonstrate its utility by applying it to a tandem reaction sequence 
involving an otherwise incompatible Lewis acid catalyst (Figure 3.1).  We also 
increase the complexity of such reactions by using the second catalyst to trap an 
intermediate from the first, forming a product that cannot be accessed when the 
reactions are performed sequentially.   
 
 
Figure 3.1.  Encapsulation of a polymeric catalyst enables a tandem reaction.  The two 
catalysts are microencapsulated PEI (1) and a nickel-based Michael addition catalyst 
(2). 
 
Results and Discussion 
A tandem amine-Lewis acid system was selected as a model because they are 
incompatible catalysts without site-isolation and because this two-catalyst system 
would be synthetically useful (vide infra).  A brief screen of the literature suggested 
that we focus on nitroalkene formation as half of our tandem reaction sequence.  This 
amine-catalyzed reaction often produces a mixture of nitroalkene and dinitro products, 
the latter being the result of a second addition of nitroalkane.19-21  If we were able to 
prepare a site-isolated amine catalyst, we could trap the nitroalkene intermediate with 
a Lewis acid catalyst in order to direct it toward a second product rather than letting it 
proceed to the dinitro product.  The Lewis acid we chose for this role is the nickel-
based Michael catalyst (2) reported by Seidel and Evans to convert nitroalkenes to the 
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corresponding Michael adduct in high yields.22  By combining these two reactions in 
one pot, we hoped to achieve a higher yield of Michael adduct than we could if the 
reactions were run sequentially. 
With the Lewis acid catalyst chosen, we assessed the necessity for developing 
an encapsulated amine catalyst23 by screening a variety of commercially available 
amine-based catalysts for the reaction between benzaldehyde (3) and nitromethane.  
Small, soluble amines were found to catalyze the reaction, producing both trans-β-
nitrostyrene (4) and 1,3-dinitro-2-phenyl-propane (5), but when used in tandem with 2 
and dimethyl malonate (DMM), the two catalysts complexed and precipitated.  On the 
other hand, amine catalysts attached to solid supports such as MCM-41 or polystyrene 
beads showed no activity toward nitroalkene formation under room temperature 
conditions suitable for catalyst 2.  Rather, they required elevated temperatures between 
60 and 90 °C to achieve nitroalkene formation. 
We sought to encapsulate the polymeric amine poly(ethyleneimine) (PEI) to 
address the compatibility and activity problems we encountered with the commercially 
available catalysts. The catalyst was prepared by dispersing a methanolic PEI solution 
into a nonpolar cyclohexane phase with the help of a stabilizer.  Upon emulsification, 
2,4-tolylene diisocyanate (TDI) was added to the continuous phase to initiate cross-
linking that occurs only at the interface of the emulsion droplets between TDI and PEI. 
After polymerization, microcapsules containing PEI chains were isolated for use in a 
reaction after drying. 
We tested our new encapsulated (µcap) amine (1) as a catalyst for nitroalkene 
formation. In this experiment, the µcaps were swollen with methanol for 5 min before 
the remaining reagents were added.  The reaction was performed at room temperature, 
and reaction progress was monitored by GC. Like the free amines, the µcap catalyst 
produces both 4 and 5 (Scheme 3.1). We currently propose that the retention of our 
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catalyst’s activity as compared to the traditionally solid-supported amines is due to the 
unique microenvironment that the capsules possess.17,18  A second phenomenon we 
observed is that the PEI-capsule walls capture intermediate 4 in an irreversible 
Michael-type addition, resulting in lowered reaction yields.25-27  
 
 
Scheme 3.1.  Single-catalyst dinitro product formation (dashed) versus double-catalyst 
Michael adduct formation (solid). 
 
The two undesired side reactions of 4 described above presented the 
opportunity to exploit a one-pot multistep reaction to its fullest potential: by adding a 
second catalyst to the system, we hoped to trap the transient nitroalkene intermediate 
and direct it toward the desired Michael adduct.  The tandem reaction was carried out 
by first swelling the encapsulated amine catalyst in methanol for 5 min and then 
suspending it in toluene.  The remaining catalyst and reagents were added, and 
reaction progress was monitored by GC.  Initial formation of nitroalkene intermediate 
was followed by its conversion to the desired Michael adduct (6) rather than undesired 
5 (Scheme 3.1). The Michael adduct was formed in 80% yield after 24 h.  It should be 
noted that 6 is not formed if only one of the catalysts is present or if the reactions are 
performed sequentially, as it was demonstrated above that the first reaction alone 
resulted in two unproductive situations.  This series of reactions is performed 
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efficiently only when the amine catalyst is encapsulated and the reactions are run in 
one pot (Table 3.1). 
 
Table 3.1.  Conversion of 3 and yield of 6 after 24 h. 
Catalyst System Conversion of 3 (%) Yield of 6 (%)a 
µcap amine (1) + Ni catalyst (2) 95 80.2 
µcap amine (1) alone 67 2.1 
Ni catalyst (2) alone 61 8.5 
Free PEI + Ni catalyst (2) 96 5.4 
aYields were determined by GC areas.  For cases in which the product was isolated, 
isolated yields agree with GC yields. 
 
In order to assess the site isolation of the two catalysts, we investigated 
whether commercially available unencapsulated PEI could replace the encapsulated 
catalyst.  We found that the two catalysts (PEI and 2) produce the Michael adduct in 
only 5.4% yield (Table 3.1, entry 4). On the basis of literature precedence, we initially 
speculated that free PEI strongly chelates Ni, making it inactive.28  This hypothesis 
was supported by the observation that the nickel-catalyzed Michael addition did not 
occur when performed in the presence of high levels of PEI (Figure 2.2).  In addition, 
by monitoring UV-Vis absorbance of 2 in the presence and in the absence of µcaps, 
we determined that the poisoning of 2 occurs only to a small extent (see Supporting 
Information).  However, when we lowered the PEI concentration to the loading 
present in the one-pot reaction, we found that the Michael addition proceeded in high 
yields, indicating that at these concentrations, the two catalysts do not foul each other 
(Figure 2.2).  The observation that the two catalysts are not incompatible at these 
loadings presents the possibility that the microcapsule shell may not provide site 
isolation in this multicatalyst system.  However, the benefit provided by the 
microcapsule shell is not negligible; though the Michael addition alone proceeds in the 
presence of free PEI, the tandem reaction does not function under these conditions.  
Table 3.1 clearly demonstrates that PEI encapsulation is necessary for the tandem 
 47 
reaction to proceed in good yield.  Whether or not the microcapsule shell provides site 
isolation, it plays a necessary role in this multicatalyst system. 
 
Conclusion 
We have demonstrated the potential for and subsequent development of an 
active, site-isolated amine catalyst.  Our encapsulation method results in a catalytically 
active species that remains site-isolated during a one-pot multistep reaction, allowing 
it to be used in tandem with an otherwise incompatible catalyst. This example 
demonstrates the capabilities of tandem catalysis to trap and direct reaction 
intermediates efficiently. The Michael adduct formed by this reaction sequence can be 
used to access pharmaceutical agents such as baclofen, rolipram, and pregabalin, as 
well as other γ-amino acid analogs. The results of this catalyst system can likely be 
made general and applied to a variety of amine-Lewis acid tandem reactions as well as 
other incompatible catalyst systems. The efficiency of organic synthesis will improve 
significantly as both site-isolation techniques and tandem reactions are developed. 
 
Afterword 
 The results presented in this chapter were a product of a true collaborative 
effort.  When I needed a site-isolated polyamine catalyst, we discovered that the 
microcapsules that Muris Kobašlija was already working with were effective for 
nitroalkene formation.  Furthermore, catalyst encapsulation plays a necessary role in 
this one-pot multicatalyst system, allowing us to access products that we could not 
access if the catalyst were not isolated or if the reactions were performed sequentially. 
The unexpected result that a second catalyst diverts the intermediate in the tandem 
catalytic reaction only increases the value of these findings.  Our initial hypothesis that 
the role of the microcapsule was to prevent incompatible catalysts from interacting 
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needs to be revisited.  Our more recent observations that low concentrations of 
unencapsulated PEI do not foul the second step, but prevents the overall reaction from 





 Dimethyl malonate (Acros, 97%), trifluoroacetic anhyhdride (Acros, 99+%), 
(±)-trans-1,2-diaminocyclohexane (Aldrich, 98%), mesitylene (Aldrich, 98%), trans-
β-nitrostyrene (Aldrich, 99%), polyisobutylene (Aldrich, MW 400, 000), tolylene 2,4-
diisocyanate (Aldrich, technical grade, 80%), chloroform (J. T. Baker), nitromethane 
(J. T. Baker, 99%), acetic anhydride (Mallinckrodt), cyclohexane (Mallinckrodt), 
methanol (Mallinckrodt), toluene (Mallinckrodt), poly(ethyleneimine) (Polysciences, 
Inc., 10,000 MW), and Span 85 (Sigma) were used as received. Benzaldehyde 
(Aldrich, 99.5%) was washed with saturated NaHCO3, distilled, and dried over 
Na2SO4 prior to use.  Reactions were rocked on a Thermolyne Speci-Mix test tube 
rocker.  For 19F elemental analysis, µcaps acylated with trifluoroacetic anhydride were 
sent to Robertson Microlit Laboratories for analysis (www.robertson-microlit.com).  
Gas chromatographic (GC) analyses were performed using a Varian CP-3800 GC 
equipped with a Varian CP-8400 autosampler, a flame ionization detector (FID) and a 
Varian CP-Sil 5CB column (length = 15 m, inner diameter = 0.25 mm, and film 
thickness = 0.25 µm. The temperature program for GC analysis held the temperature 
constant at 80 ºC, heated samples from 80 to 200 ºC at 17 ºC/min, and held at 200 ºC 
for 2 min. Inlet and detector temperatures were set constant at 220 and 250 ºC, 
respectively. Mesitylene was used as an internal standard to calculate reaction 
conversion.  1H NMR and 13C NMR spectra were recorded on a Varian Inova-400 
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(400 MHz) spectrometer and are reported in ppm using solvent as an internal standard 
(CDCl3 at 7.26 ppm).  Data are reported as s = singlet, d = doublet, t = triplet, quin = 
quintet, m = multiplet.  Scanning electron microscopy images were obtained on a 
Leica 440 SEM at the Cornell Center for Materials Research.  Capsules were 
characterized at 25 kV after sputter coating with palladium-gold.  Optical microscopy 
images were obtained on an inverted Leica DMIL with a mounted Sony DSC-F717 
digital camera and ebq100 UV source. 
 
Synthesis of Microencapsulated Poly(ethyleneimine) Catalyst (1).  The 
microcapsule catalyst was prepared by interfacial polymerization of oil-in-oil 
emulsions, in a slightly different manner than what was described by Kobašlija and 
McQuade.29  To cyclohexane (50 mL, η = 9.5 cp) and Span 85 mixture  (2% v/v) 
stirred at 1500 rpm with a magnetic stirrer, the disperse phase (1.5 mL PEI in 6.0 mL 
methanol and 1.5 mL chloroform) was added at once.  After 2 minutes of stirring, 2,4-
tolylene diisocyanate (TDI, 1.0 mL in 9.0 mL cyclohexane) was added at once and the 
stirring was reduced to 500 rpm.  After 1 minute, polymerization was stopped by the 
addition of cyclohexane (30 mL).  The resulting capsules were left to settle, further 
washed with hexanes, and left to air-dry overnight. 
 
Determination of Catalyst Loading. Loading of the microcapsule catalyst active 
sites was determined via labeling with fluorine and a subsequent fluorine elemental 
analysis.  To microcapsule catalyst (100 mg), loaded in a syringe equipped with a frit, 
methanol (5 mL) was added to swell them.  After 5 minutes the excess methanol was 
removed and the solution containing trifluoroacetic anhydride (1 mL) in methanol (5 
mL) was drawn into the syringe.  The mixture was rocked at room temperature 
overnight.  Fluorine labeled microcapsule catalysts were extensively washed with 
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methanol, dried under stream of N2 and sent for fluorine elemental analysis.  To 
ensure that all the active site were acylated, the microcapsules were checked for the 
activity in nitro-aldol reaction.  As expected for fully acylated microcapsules, they 
have shown no activity.  Results of fluorine elemental analysis suggest that the loading 
of the catalytically active sites is 4.7 mmol/g. 
 
Ni(II)–bis[(±)-trans -N,N’-Dibenzylcyclohexane-1,2-diamine]Br2 (2).  Prepared 
according to the method of Evans et al.22  (±)-trans-1,2-Diaminocyclohexane (3 g, 26.3 
mmol) was dissolved in MeOH (16 mL) and the solution was heated to reflux.  
Benzaldehyde (5.4 mL, 53.2 mmol) was added dropwise and the reaction was stirred 
at reflux for 30 min.  The reaction was allowed to cool to room temperature and was 
left to sit overnight, during which the product precipitated out of solution.  The solid 
was isolated by filtration and recrystallized from petroleum ether to afford (±)-trans-
dibenzylidenecyclohexane-1,2-diamine as white crystals (6.57 g, 86% yield): 1H NMR 
(CDCl3, 300 MHz): δ 8.22 (s, 2H), 7.61 (m, 4H), 7.34 (m, 4H), 3.42 (m, 2H), 1.89 (m, 
8H), 1.50 (m, 2H); 13C NMR (CDCl3, 75 MHz): δ 161.3, 136.6, 130.4, 128.6, 128.2, 
74.0, 33.2, 24.7. 
 
(±)-trans-Dibenzylidenecyclohexane-1,2-diamine (6.57 g, 22.6 mmol) was dissolved 
in MeOH (55 mL) and cooled to 0 °C.  NaBH4 (1.8 g, 47.6 mmol) was added slowly, 
after which the reaction was stirred at reflux for 15 min.  Once cool, the solution was 
acidified with 5 M HCl and washed with CH2Cl2.  The layers were separated and 1 M 
NaOH was added to the aqueous layer until pH = basic.  The product was extracted 
with CH2Cl2 (3 x 50 mL) and the combined organic layers were dried over Na2SO4, 
concentrated, and dried under vacuum to give (±)-trans-dibenzylcyclohexane-1,2-
diamine as a white solid (6.58 g, 99% yield): 1H NMR (CDCl3, 400 MHz): δ 7.30-7.19 
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(m, 10H), 3.90 (d, 2H), 3.63 (d, 2H), 2.31 (m, 2H), 2.18 (d, 2H), 1.72 (m, 2H), 1.23-
1.03 (m, 4H); 13C NMR (CDCl3, 100 MHz): δ 141.1, 128.6, 128.4, 128.3, 127.0, 61.1, 
51.1, 31.7, 25.2.  (±)-trans-dibenzylcyclohexane-1,2-diamine (3.66 g, 12.4 mmol) was 
dissolved in acetonitrile (150 mL).  NiBr2 (1.26 g, 5.8 mmol) was added and the 
reaction was stirred at reflux for 6 h, during which the reaction turned purple.  Upon 
cooling, the blue solution was filtered through a glass frit and concentrated in vacuo.  
The crude product was recrystallized from CH2Cl2 and acetonitrile to give Ni(II)–
bis[(±)-trans -N,N’-dibenzylcyclohexane-1,2-diamine]Br2 as blue crystals (3.46 g, 
74% yield). 
 
General Procedure for Multicatalyst Reaction.  Microencapsulated PEI catalyst 1 
was swollen in methanol before use.  Catalyst(s), benzaldehyde (101.6 µL, 1 mmol), 
nitromethane (0.54 mL, 10 mmol), dimethyl malonate (114.3 µL, 1 mmol), methanol 
(0.5 mL), toluene (1 mL), and mesitylene (13.9 µL) were placed in a 4 mL glass vessel 
and sealed with a screw cap. The reaction was rocked at room temperature on a rocker. 
Reaction conversion was monitored by withdrawing aliquots from the reaction at 
different time intervals, diluting with methylene chloride, and analyzing by GC with 
reference to mesitylene. 
 
Tandem catalysis: PEI catalyst 1 (15 mg) and nickel catalyst 2 (60 mg, 7.4 mol %) 
were used in the reaction described above. 
 




Nickel catalyst (2) only: Nickel catalyst 2 (60 mg, 7.4 mol %) was used in the 
reaction described above. 
 
Free PEI and nickel catalyst 2: PEI (10,000 MW, 25 mg) and nickel catalyst 2 (60 
mg, 7.4 mol %) were used in the reaction described above. 
 
trans-β-Nitrostyrene (4).  The product can be commercially obtained from Aldrich 
for comparison purposes.  1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 13.65 Hz, 1H), 
7.53 (d, J = 13.65 Hz, 1H), 7.48-7.35 (m, 5H); 13C NMR (100 MHz, CDCl3) δ 139.1, 
137.1, 132.2, 130.1, 129.4, 129.3. 
 
1,3-Dinitro-2-phenyl-propane (5).  The product can be purified by column 
chromatography (20%EtOAc/hexanes) to give a brown oil.  1H NMR (400 MHz, 
CDCl3) δ 7.36-7.29 (m, 3H), 7.2-7.17 (m, 2H), 4.76-4.65 (m, 4H), 4.3-4.22 (quin, J = 
7.21 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 134.5, 129.7, 129.2, 127.6, 76.9, 41.9. 
 
Methyl 2-carboxymethoxy-4-nitro-3-phenyl-butyrate (6).  The product can be 
purified by column chromatography (20% EtOAc/hexanes) to give a white solid.  1H 
NMR (400 MHz, CDCl3) δ 7.33-7.26 (m, 3H), 7.24-7.21 (m, 3H), 4.95-4.84 (m, 2H), 
4.24 (dt, J = 5.1 Hz, 9.0 Hz, 1H), 3.86 (d, J = 9.16, 1H), 3.75 (s, 1H), 3.54 (s, 1H); 13C 




 Experimental methods and catalyst preparation and characterization are located 
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Mechanism and Application of a Microcapsule Enabled Multicatalyst Reaction 
 
Preface 
 The development of the reaction described in Chapter 3 provided us with our 
first multicatalyst system.  It also presented us with a number of answered questions as 
to why and how the reaction worked.  The work presented in this chapter addresses 
some of these questions, exploring both the conditions required by the 
microencapsulated catalyst as well as the kinetics of the one-pot reaction.  
 
Abstract* 
In this paper, we describe the development and application of a multistep one-
pot reaction that is made possible by catalyst encapsulation.  We prepared a 
microencapsulated amine catalyst by interfacial polymerization and used it in 
conjunction with a nickel-based catalyst for the transformation of an aldehyde to a 
Michael adduct via a nitroalkene intermediate.  The amine-catalyzed conversion of an 
aldehyde to a nitroalkene was found to proceed through an imine rather than a 
nitroalcohol.  Kinetic studies indicated that the reaction is first order in both the nickel 
catalyst and the shell of the encapsulated amine catalyst.  Furthermore, we present 
kinetic data that demonstrates that there is a rate enhancement of the Michael addition 
due to the presence of the microencapsulated catalyst.  We applied our one-pot 
reaction to the development of a new synthetic route for pregabalin that proceeds with 
an overall yield of 74%. 
 
                                                
* Reproduced in part with permission from: Poe, S. L.; Kobašlija, M.; McQuade, D. T. 
J. Am. Chem. Soc. 2007, 129, 9216.  Copyright 2007 American Chemical Society. 
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Introduction 
Catalyst isolation techniques that enable one-pot multistep reactions hold great 
potential for increasing the efficiency of chemical synthesis.  Performing multiple 
reactions simultaneously in a single reaction vessel offers possibilities for reduced 
waste and increased safety as well as manipulation of equilibria.1-3  Although many 
site-isolated catalysts have been developed, the focus has been largely on catalyst 
recovery rather than on tandem catalysis. Indeed, since the pioneering work of 
Patchornik over 25 years ago4 the sol-gel materials developed by Avnir and Blum 
have been the only catalyst supports used in the context of one-pot multistep catalysis 
until recently.5-7  In the past few years, Fréchet et al. introduced a multicatalyst system 
that employed star polymers for catalyst isolation,8 while Jones et al. showed that 
catalysts supported on polymer resins and magnetic particles could be used together 
while avoiding catalyst fouling.9  In another approach Kaneda et al. immobilized two 
incompatible catalysts in mesoporous clays to achieve site isolation.10  All of these 
examples demonstrate the effective separation of otherwise incompatible catalysts.  
Though each of these examples promises the possibility for application to more 
sophisticated systems, the full potential of multicatalyst systems will remain 
unrealized until applications to more complex molecules are demonstrated. 
With this need in mind, we recently reported a microcapsule (µcap) enabled 
multicatalyst system that produces a synthetically useful product.7  Though the goal of 
microencapsulation was for the microcapsule shell to provide site-isolation, we 
discovered that in practice, the two catalysts may interact after all.  Regardless, we 
demonstrated that microencapsulation is necessary for a functional two-catalyst 
system, and despite the potential absence of site-isolation, we were able to develop a 
tandem reaction that would not otherwise be possible.  The reaction involves the 
amine-catalyzed transformation of an aldehyde to a nitroalkene followed by a 
 57 
transition-metal-catalyzed Michael addition in the same reaction vessel (Scheme 4.1).  
Typically, amine catalysts and nickel complexes are incompatible due to their 
tendency to chelate and render each other inactive.11  However, microencapsulation of 
PEI forms catalyst 1, which can successfully be used in tandem with the nickel-based 
catalyst 2 developed by the Evans group.12   
 
 
Scheme 4.1.  Transformation of an aldehyde to a nitroalkene and subsequent Michael 
addition of a malonate ester can be performed in tandem through the use of 
microencapsulated catalyst 1 and nickel catalyst 2.  
 
Not only do these two reactions both form C-C bonds, but together they create 
a versatile synthetic building block.  For instance, the nitroalkane can be converted 
into an amine via reduction or a carbonyl via the Nef reaction, while the ester groups 
can be transformed into a single carboxylate via hydrolysis-decarboxylation or a diol 
via reduction.  Such subsequent reactions could provide access to a wide range of 
useful intermediates, such as those found en route to pharmaceuticals ranging from 




Scheme 4.2.  Pharmaceutical agents that incorporate an aldehyde, a nitroalkane, and a 
malonate ester. 
 
With this work, we show the generality of this reaction while providing 
mechanistic insight for our microencapsulated catalyst.  We also discuss the 
application of this system to a pharmaceutically relevant problem: an efficient 
chemical synthesis of pregabalin. 
 
Results and Discussion 
Synthesis and Characterization of Microencapsulated Catalyst. 
Encapsulation of an amine-based Henry reaction catalyst was achieved via the 
interfacial polymerization of oil-in- oil emulsions, as described in our previous work.  
Poly(ethyleneimine) (PEI) was encapsulated by dispersing a methanolic PEI solution 
into a continuous cyclohexane phase.  Upon emulsification, 2,4-tolylene diisocyanate 
(TDI) was added to initiate cross-linking at the emulsion interface, forming polyurea 
shells that contain free chains of PEI. The microcapsules crenate when dry and swell 
when placed in such solvents as methanol and DMF, suggesting a hollow capsule 
rather than a solid sphere (Figure 4.1).13  Catalyst loading was determined to be 1.6 
mmol/g14 by acylation of the catalytic amines with trifluoroacetic anhydride followed 
by fluorine elemental analysis.  Oxygen elemental analysis placed the upper limit on 
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Figure 4.1. Optical micrographs of dry µcaps (a); µcaps in methanol, a swelling 
solvent (b); and µcaps in toluene, a nonswelling solvent (c). The scale bar is 30 µm. 
 
Activity and Mechanism of Microencapsulated Catalyst.  To better 
understand the importance of µcap swelling, the reaction between benzaldehyde (4) 
and nitromethane was performed in a range of different solvents.15  Swelling effects 
were separated from solvent effects by using both free and encapsulated PEI as 
catalysts for formation of trans-β-nitrostyrene (5) and 1,3-dinitro-2-phenyl-propane 
(6). Figure 4.2 shows benzaldehyde conversion after 6 h for each catalyst. 
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Figure 4.2.  Conversion of benzaldehyde (4) after 6 h for the amine-catalyzed reaction 
between benzaldehyde and nitromethane. Catalysts for the reaction were free PEI 
(black bars, 4.6 mol %) and encapsulated PEI (white bars, 4.6 mol %). 
 
The results for the reactions catalyzed by free PEI (black bars) are not affected 
by swelling or by the kinetic barrier introduced by the microcapsule shell and 
therefore indicate how effective each solvent is for this reaction.  If the differences in 
conversion for the reactions catalyzed by encapsulated PEI (white bars) were based 
exclusively on solvent, we would expect the two cases to show the same trends.  This 
is the case for both swelling and partially swelling solvents; for each catalyst 
conversions are high for ethanol, moderate for chloroform, and low for acetone. 
However, this is not true for non-swelling solvents.  While the free PEI-catalyzed 
reactions revealed that toluene, ether, and THF were relatively good, moderate, and 
poor solvents, respectively, encapsulated PEI did not produce the same results.  
Despite the moderate conversion produced by free PEI in toluene, encapsulation 
resulted in an 80% decrease in catalytic activity in the same solvent.  These results 
suggest that the solvent dependence of this reaction is two-fold; not only must the 
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solvent be favorable for the PEI-catalyzed reaction, but it also must be able to swell 
the microcapsules.  Acetone swells the capsules but is a poor solvent for the reaction, 
while toluene is a good solvent for the reaction but is unable to swell the µcaps.  
Both of these cases result in poor conversions of benzaldehyde when 
encapsulated PEI is used as the catalyst.  Only ethanol, a good solvent for the reaction 
that is also able to swell the capsules, is able to produce high conversions with both 
free and encapsulated PEI.  Furthermore, in some cases catalytic activity is retained 
for capsules that are swollen in a swelling solvent and then placed in a bulk non-
swelling solvent (Figure 4.2).  We are currently pursuing the reasons for and 
implications of this phenomenon.16 
With a better understanding of the conditions required for catalytic activity, we 
turned our attention to the mechanism of the µcap catalyst.  Transformation of an 
aldehyde to a nitroalkene can occur via two different pathways.  The first involves 
nitroalcohol formation through a traditional Henry reaction, which is then followed by 
elimination to form the double bond.  The second proceeds through an imine 
intermediate rather than the nitroalcohol.  This latter mechanism has been suggested 
for cases in which the catalyst contains both primary and tertiary amino groups as well 
as for solid supported catalysis.17,18  Being that our catalyst exhibits both of these 
features, we predicted that µcap-enabled nitroalkene formation goes through an imine 
intermediate rather than the nitroalcohol.  Indeed, when we followed the µcap-
catalyzed condensation of benzaldehyde with nitromethane over time, we did not 
observe the nitroalcohol at any point in the reaction.  However, the nitroalcohol was 
found to be present during the course of the one-pot reaction, possibly having been 
formed by the amine ligands of the nickel catalyst.  This evidence precludes the 
possibility that elimination occurs as soon as the nitroalcohol is formed and suggests 
that the reaction might follow the latter route.  To further support this hypothesis, 
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when the nitroalcohol is placed in the presence of swollen µcaps, no nitroalkene 
formation is observed.  The inability of the µcap catalyst to convert this potential 
intermediate to the final product provides further evidence against the nitroalcohol-
elimination pathway.  A proposed mechanism for µcap-catalyzed nitroalkene 
formation is shown in Scheme 4.3. 
 
 
Scheme 4.3.  Proposed catalytic system of µcap-catalyzed nitroalkene formation. 
Though the mechanism for nitroalkene formation and regeneration of the primary 
amine (left) is believed to occur intermolecularly, it is shown intramolecularly for 
clarity. 
 
One-Pot Reaction. We reported that there is the possibility for the nitroalkene 
intermediate to either form the dinitro product or go through a Michael-type addition 
with the encapsulated PEI when subjected to the reaction discussed above.  However, 
we have also shown that when the reaction is run in the presence of a second catalyst-
reagent pair, this intermediate can be trapped and directed to a different reaction 
pathway (Scheme 4.4).  
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Scheme 4.4.  Single-catalyst addition of nitromethane (top) versus double-catalyst 
addition of dimethyl malonate (DMM) (bottom). 
 
Furthermore, because µcaps swollen in methanol retain their catalytic activity 
when placed in toluene, the reaction can be run in a mixture of two different solvents.  
This allows both the µcaps and the nickel catalyst to operate in their respective ideal 
solvents of methanol and toluene.  To demonstrate the scope of this one-pot reaction, 
we performed this reaction with a variety of aromatic and aliphatic aldehydes.  The 
results are shown in Table 4.1.  It is evident that though the system tolerates both 
aromatic and aliphatic aldehydes, introduction of electron-withdrawing substituents on 
the aromatic substrates results in decreased yields.  This effect is most pronounced in 
entries 6 and 7 for which the cyano- and nitro-substituted benzaldehydes yield 
minimal product formation.  Assuming that the µcap-catalyzed step proceeds through 
an imine intermediate, this phenomemon can be rationalized by the observations of 
Santerre et al., who compared the rates of uncatalyzed imine formation between 
substituted benzaldehydes and aliphatic amines at room temperature.19  It was found 
that the rate is maximal for unsubstituted benzaldehyde and steadily decreases as the 
substituents’ σ values diverge in either direction on the Hammett plot.  It is possible 
that the cyano and nitro substituents are too electron-withdrawing to allow for any 






Table 4.1.  Scope of the one-pot reaction. 
 
Entry R Product Yield (%) 
1 Ph 7a 80 
2 4-Me—Ph 7b 94 
3 4-MeO—Ph 7c 89 
4 4-Br—Ph 7d 43 
5 4-Cl—Ph 7e 48 
6 4-CN—Ph 7f <5 
7 4-NO2—Ph 7g <5 
8 CH(Me)2 7h 71 
9 CH2CH(Me)2 7i 65 
 
To gain information about the mechanism of the overall tandem reaction, we 
carried out kinetic studies to identify the rate-determining step.  Changing the catalyst 
concentration in the reaction between 3-methylbutyraldehyde (8), nitromethane, and 
dimethyl malonate revealed that the reaction is first order in nickel catalyst 2 (Figure 
4.3), indicating that the Michael addition of dimethyl malonate to the nitroalkene is the 
rate-determining step. 
The kinetic data shown in Figure 4.3 reveal that the rate of the tandem reaction 
depends on the concentration of nickel catalyst 2. It is therefore instructive to 
determine whether the rate-determining step is at all retarded by the interaction 




Figure 4.3.  Kinetic studies on the tandem reaction of 3-methylbutyraldehyde, 
nitromethane, and dimethyl malonate. 
 
We began our investigation by comparing the rates of the Michael addition in 
the absence and presence of the microencapsulated catalyst.  One complicating factor, 
however, is that the catalytic amines within the µcaps irreversibly react with 
nitroalkenes, decreasing the amount of starting material available for reaction.  Using 
the Michael addition between trans-β-nitrostyrene (5) and dimethyl malonate as a 
model, we approached this problem in two ways.  The first approach was to 
“normalize” the data from the µcap-containing reaction in order to account for the loss 
of starting material (Figure 4.4a).  Product yields were calculated using the formula 
(mol of 7a)/(mol of 5 + mol of 7a).  It should be noted that these calculations correct 
only for decreased product formation due to nitroalkene-µcap interaction; any product 
suppression due to catalyst interaction should still be apparent.  Both reactions attain 
an adjusted yield of 90% after 10 h, indicating that the presence of the µcaps does not 
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depress the rate of the Michael addition. Indeed, they instead appear to provide rate 
enhancement as the µcap-containing reaction reached its final yield after only 4 h. 
To demonstrate that the apparent rate enhancement is not merely an artifact of 
data correction, we acylated the reactive amines in order to prevent their reaction with 
5.  The data shown in Figure 4.4b confirms the rate enhancement in the presence of 
microcapsules.  Our initial explanation of these results is based on previous studies 
reporting the acceleration of Michael additions by ureas and thioureas.20  Since the 
capsule walls are composed of polyurea, we suggested that this was the reason that we 
observe the same phenomenon in our system, and proposed the transition state for the 
tandem reaction in Figure 4.5.   Later, however, we determined that the urea groups 
are not responsible for the observed rate enhancement.  This work will be discussed in 
Chapter 5.  Upon further investigation into this rate enhancement, the reaction proved 
to be first order in the concentration of acylated microcapsules (Figure 4.6). This 
finding indicates that the presence of the µcaps accelerates the Michael addition and 
ultimately the overall one-pot reaction.  In addition, this rate enhancement does not 
appear to be accompanied by any degradation in yield, suggesting that the interaction 








Figure 4.4.  µcap-accelerated Michael addition between benzaldehyde (4) and 
dimethyl malonate in the presence of untreated µcaps (a) and in the presence of 




Figure 4.5.  Proposed transition state for the tandem reaction. 
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Figure 4.6.  Order plot for the Michael addition between benzaldehyde (4) and 
dimethyl malonate in the presence of acylated µcaps. Rate is plotted as a function of 
nickel catalyst 2. 
 
Enantioselective Synthesis of Pregabalin.  An attractive feature of our two-
step one-pot reaction is that it not only incorporates an innovative technique for site-
isolation but also produces synthetically useful products when an enantioselective 
version of 2 is used.  The Michael adducts that are created are precursors to γ-amino 
acids, allowing access to γ-amino butyric acid (GABA) analogs.  Pregabalin is one 
such analog that is approved for the treatment of both epilepsy and neuropathic pain.  
We imagined a synthesis of pregabalin where our two-catalyst system forms the 
pregabalin backbone efficiently and enantioselectively.  The desirability of performing 
these reactions in tandem rather than sequentially is evident when one considers the 
difficulty of isolating of the nitroalkene intermediate.  An efficient nitroalkene-
forming reaction between 3-methylbutyraldehyde (8) and nitromethane has only been 
reported once21 and in our hands often yields a significant amount of byproducts.  
However, we demonstrated that with our one-pot reaction there is no need for 




Scheme 4.5.  Synthesis of pregabalin (3). Reagents and conditions: (a) nitromethane, 
dimethyl malonate, 1, 2, toluene, methanol, room temperature, 48 h, 94%, 72% ee. (b) 
Raney Ni, H2 (45 psi), EtOH, room temperature, 18 h, 96%. (c) 5 M HCl, 115 °C, 18 
h, 95%, 72% ee. 
 
The total synthesis of pregabalin is depicted in Scheme 4.5.  Using 3-
methylbutyraldehyde (8) as the starting material and an enantioselective version of 
nickel catalyst 2, the tandem reaction produced the corresponding Michael adduct (S)-
7i in 94% yield and 72% ee.  It should be noted that this tandem catalysis system 
efficiently suppressed the yield of the undesired dinitro byproduct to less than 5%.  
Overnight hydrogenation of (S)-7i with Raney Ni gave nearly quantitative conversion 
to the ring-closed product 9.  Subsequent acid hydrolysis and decarboxylation 
proceeded in 95% yield of the HCl salt of pregabalin (3), which retains an ee of 72%.  
It has been reported that enantiomeric enrichment of pregabalin can be achieved by 
recrystallization for cases in which the ee is at least 85% of the S-enantiomer.22  
Treatment of the 72% ee HCl salt with base followed by a single recrystallization from 
isopropyl alchol/water afforded a product with 91.5% ee.  Our successful enrichment 
demonstrates the viability of obtaining an enantiomerically pure product without the 
need for a resolution step, which would bring the overall yield of this synthesis to 74% 





We developed and evaluated a two-step reaction that is capable of converting 
both aromatic and aliphatic aldehydes to their corresponding Michael adducts in a 
single reaction vessel.  The two-catalyst system was made possible by 
microencapsulation of PEI in order to two otherwise incompatible catalysts 
compatible.  Kinetic studies indicated that the presence of the microcapsule shell of 
catalyst 1 enhanced the rate of the reaction promoted by catalyst 2.  Therefore, the 
microcapsules not only make the reaction possible by imparting compatibility, but 
they also serve a second function by enhancing the rate-determining step.  Using this 
tandem reaction we achieved a three-step total synthesis of pregabalin in 74% overall 
yield, demonstrating the applicability of this system to creating synthetically 
interesting compounds.  By obtaining a better understanding of this complex 
multicomponent system, we continue to make progress toward the development of 
similar tandem reactions. 
 
Afterword 
 This work provided us with much information about our multicatalyst system.  
For example, we noticed interesting phase separation behavior upon swelling the 
capsules in multiple solvents, and Muris Kobašlija went on to explore this 
phenomenon in more detail.  However, as chemistry always does, our results led to 
even more questions, such as the origin of the rate enhancement of the Michael 








Celite 545 (Acros), 4-cyanobenzaldehyde (Acros, 98%), isobutyraldehyde 
(Acros, 99+%), isovaleraldehyde (Acros, 98%), 4-nitrobenzaldehyde (Acros, 99%), p-
tolualdehyde (Acros, 99+%), trifluoroacetic anhyhdride (Acros, 99+%), valeraldehyde 
(Acros, 98%), (±)-trans-1,2-diaminocyclohexane (Aldrich, 98%), mesitylene (Aldrich, 
98%), trans-β-nitrostyrene (Aldrich, 99%), polyisobutylene (Aldrich, MW 400, 000), 
Raney Ni (Aldrich, pH 10, 50% solution in water), tolylene 2,4-diisocyanate (Aldrich, 
technical grade, 80%), (1S,2S)-(+)-1,2-diaminocyclohexane (Alfa Aesar, 98%), 
chloroform (J. T. Baker), hydrochloric acid (J. T. Baker, 36.5-38%), nitromethane (J. 
T. Baker, 99%), acetic anhydride (Mallinckrodt), cyclohexane (Mallinckrodt), 
methanol (Mallinckrodt), toluene (Mallinckrodt), ethanol (Pharmaco-AAPER, 200 
proof), branched poly(ethyleneimine) (Polysciences, Inc., 10,000 MW), p-
anisaldehyde (Sigma), and Span 85 (Sigma) were used as received.  Dimethyl 
malonate (Acros, 97%) and benzaldehyde (Aldrich, 99.5%) were washed with 
saturated NaHCO3, distilled, and dried over Na2SO4 prior to use.  4-
Bromobenzaldehyde (Aldrich, 99%) and 4-chlorobenzaldehyde (Aldrich, 97%) were 
recrystallized from 95% EtOH prior to use.  Reactions were rocked on a Thermolyne 
Speci-Mix test tube rocker.  Hydrogenations were performed in a PARR 
hydrogenation apparatus 3911EA.  For 19F elemental analysis, µcaps acylated with 
trifluoroacetic anhydride were sent to Robertson Microlit Laboratories for analysis 
(www.robertson-microlit.com).  For 16O elemental analysis, µcaps were sent to 
Elemental Analysis, Inc. for analysis (elementalanalysis.com).  Gas chromatographic 
(GC) analyses were performed using a Varian CP-3800 GC equipped with a Varian 
CP-8400 autosampler, a flame ionization detector (FID) and a Varian CP-Sil 5CB 
column (length = 15 m, inner diameter = 0.25 mm, and film thickness = 0.25 µm. The 
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temperature program for GC analysis held the temperature constant at 80 ºC, heated 
samples from 80 to 200 ºC at 17 ºC/min, and held at 200 ºC for 2 min. Inlet and 
detector temperatures were set constant at 220 and 250 ºC, respectively. Mesitylene 
was used as an internal standard to calculate reaction conversion.  High Performance 
Liquid Chromatography (HPLC) analyses were performed using a Hewlett-Packard 
Series II 1090 Liquid Chromatograph equipped with an autosampler HP 79846A, a 
solvent delivery system HP 79835A and a diode-array detector HP 79883A.  1H NMR 
and 13C NMR spectra were recorded on a Varian Inova-400 (400 MHz) spectrometer 
and are reported in ppm using solvent as an internal standard (CDCl3 at 7.26 ppm).  
Data are reported as s = singlet, d = doublet, t = triplet, quin = quintet, m = multiplet.  
Optical microscopy images were obtained on an inverted Leica DMIL with a mounted 
Sony DSC-F717 digital camera and ebq100 UV source. 
 
Synthesis of Microencapsulated Poly(ethyleneimine) Catalyst (1).  The catalyst 
was prepared as described in the Experimental Section of Chapter 3. 
 
Determination of Catalyst Loading.  Primary amine loading for the microcapsule 
catalyst was determined via labeling with fluorine and a subsequent fluorine elemental 
analysis.  To microcapsule catalyst (100 mg), loaded in a syringe equipped with a frit, 
methanol (5 mL) was added to swell them.  After 5 minutes the excess methanol was 
removed and the solution containing trifluoroacetic anhydride (1 mL) in methanol (5 
mL) was drawn into the syringe.  The mixture was rocked at room temperature 
overnight.  Fluorine labeled microcapsules were extensively washed with methanol, 
dried under stream of N2 and sent for fluorine elemental analysis.  To ensure that all 
the active sites were acylated, the microcapsules were checked for the activity in 
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nitroalkene formation.  As expected for fully acylated microcapsules, showed no 




where “N” is any amine that is capable of being trifluoroacylated (1o and 2o amines).  
Since the primary, secondary, and tertiary amines of PEI statistically exist in a 1:2:1 
ratio, the loading of 1o amines in the microencapsulated catalyst is approximately 1.55 
mmol/g. 
 
The 1o amine loading of 10,000 MW PEI was calculated based on the assumption that 
the primary, secondary, and tertiary amines exist in a 1:2:1 ratio, as stated by the 
vendor.  The 1o amine loading was calculated to be 5.81 mmol/g. 
 
The urea loading of the microencapsulated catalyst was determined by oxygen 
elemental analysis after the µcaps were dried under vacuum.  Results indicated that the 









Assuming that 5.64 mmol O/g is due to urea groups, there are 4.26 mmol O/g due to 
the acylation of 1o and 2o amines, consistent with the findings above. 
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Ni(II)–bis[(±)-trans -N,N’-Dibenzylcyclohexane-1,2-diamine]Br2 (2).  Prepared 
according to the method of Evans et al.12 and as described in the Experimental Section 
of Chapter 3 using (±)-trans-1,2-diaminocyclohexane or (1S-2S)-(+)-
diaminocyclohexane as the starting material. 
 
General Procedure for µcap-Catalyzed Reaction Solvent Study.  Either free PEI 
(7.9 mg, 4.6 mole % 1oamines) or encapsulated PEI (1, 30 mg, 4.6 mole % 1o amines) 
was placed in a 4 mL glass vessel.  Solvent (1 mL) was added, and the vessel was 
sealed and allowed to stand at 297 K overnight.  For the 1:3 ethanol:toluene mixture, 
the caps were swollen in 0.25 mL ethanol for 10 minutes before the addition of 0.75 
mL toluene.  Benzaldehyde (4, 101.6 µL, 1 mmol), nitromethane (0.54 mL, 10 mmol), 
and mesitylene (13.9 µL, 0.1 mmol) were added.  The vessel was sealed and the 
reaction was rocked at 297 K on a rocker.  Reaction conversion was monitored by 
withdrawing aliquots from the reaction at different time intervals, diluting with 
methylene chloride, and analyzing by GC with reference to mesitylene. 
 
trans-β-Nitrostyrene (5).  The title compound can be commercially obtained from 
Aldrich for comparison purposes.  1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 13.65 
Hz, 1H), 7.53 (d, J = 13.65 Hz, 1H), 7.48-7.35 (m, 5H); 13C NMR (400 MHz, CDCl3) 
δ 139.1, 137.1, 132.2, 130.1, 129.4, 129.3. 
 
1,3-dinitro-2-phenyl-propane (6).  The title compound can be purified by column 
chromatography (20%EtOAc/hexanes) to give a brown oil.  1H NMR (400 MHz, 
CDCl3) δ 7.36-7.29 (m, 3H), 7.2-7.17 (m, 2H), 4.76-4.65 (m, 4H), 4.3-4.22 (quin, J = 
7.21 Hz, 1H); 13C NMR (400 MHz, CDCl3) δ 134.5, 129.7, 129.2, 127.6, 76.9, 41.9. 
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General Procedure for Tandem Reaction.  Microencapsulated PEI catalyst (1, 15 
mg, 6.9 mol %) was swollen in 0.5 mL methanol in a 4 mL glass vessel before use.  
Nickel catalyst (2, 60 mg, 7.4 mol %), aldehyde (1 mmol), nitromethane (0.54 mL, 10 
mmol), dimethyl malonate (114.3 µL, 1 mmol), and toluene (1 mL) were added to the 
vessel, which was sealed with a screw cap.  The reaction was rocked at room 
temperature on a rocker for 24 hours.  The volatile components were removed under 
reduced pressure and the crude product was purified by column chromatography. 
 
Methyl-2-carbomethoxy-4-nitro-3-phenyl-butyrate (7a).  The title compound can 
be purified by column chromatography (20% EtOAc/hexanes) to give a white solid.  
1H NMR (400 MHz, CDCl3) δ 7.33-7.26 (m, 3H), 7.24-7.21 (m, 3H), 4.95-4.84 (m, 
2H), 4.24 (dt, J = 5.1 Hz, 9.0 Hz, 1H), 3.86 (d, J = 9.16, 1H), 3.75 (s, 1H), 3.54 (s, 
1H); 13C NMR (400 MHz, CDCl3) δ 168.1, 167.5, 136.4, 129.3, 128.7, 128.1, 77.6, 
54.9, 53.3, 53.1, 43.2. 
 
Methyl-2-carbomethoxy-4-nitro-3-(4-methylphenyl)butyrate (7b).  The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
white solid.  1HNMR (400 MHz, CDCl3) δ 7.16-7.10 (m, 4H), 4.93-4.86 (dd, 2H), 
4.24-4.18 (m, 1H), 3.87-3.84 (d, 1H), 3.79 (s, 3H), 3.60 (s, 3H), 2.33 (s, 3H); 13CNMR 
(400 MHz, CDCl3) δ 168.1, 167.5, 138.3, 133.2, 129.9, 127.9, 77.7, 55.0, 53.2, 53.2, 
53.0, 42.8, 21.3. 
 
Methyl-2-carbomethoxy-4-nitro-3-(4-methoxyphenyl)butyrate (7c). The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
white solid.  1HNMR (400 MHz, CDCl3) δ 7.18-7.15 (d, 2H), 6.83-6.80 (d, 2H), 4.90-
4.83 (dd, 2H), 4.23-4.17 (m, 1H), 3.83-3.81 (d, 1H), 3.80 (s, 3H), 3.79 (s, 3H), 3.59 (s, 
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3H); 13CNMR (400 MHz, CDCl3) δ 168.1, 167.5, 159.7, 129.2, 128.1, 114.6, 77.9, 
55.4, 55.1, 53.2, 53.1, 42.5, 12.1. 
 
Methyl-2-carbomethoxy-4-nitro-3-(4-bromophenyl)butyrate (7d). The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
colorless oil.  1HNMR (400 MHz, CDCl3) δ 7.48-7.44 (d, 2H), 7.16-7.12 (d, 2H), 
4.97-4.82 (m, 2H), 4.28-4.20 (dt, 1H), 3.86-3.82 (d, 1H), 3.78 (s, 3H), 3.60 (s, 3H); 
13CNMR (400 MHz, CDCl3) δ 167.8, 167.2, 135.4, 132.4, 129.8, 122.7, 77.3, 54.6, 
53.3, 53.2, 42.6. 
 
Methyl-2-carbomethoxy-4-nitro-3-(4-chlorophenyl)butyrate (7e). The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
colorless oil.  1HNMR (400 MHz, CDCl3) δ 7.36-7.32 (d, 2H), 7.20-7.16 (d, 2H), 
4.96-4.88 (m, 2H), 4.26-4.20 (m, 1H), 3.83-3.80 (d, 1H), 3.77 (s, 3H), 3.60 (s, 3H); 
13CNMR (400 MHz, CDCl3) δ 167.8, 167.3, 134.9, 143.5, 129.6, 129.4, 77.4, 54.6, 
53.3, 53.1, 42.5. 
  
Methyl-2-carbomethoxy-3-(nitromethyl)-4-methylpentanoate (7h). The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
colorless oil.  1HNMR (400 MHz, CDCl3) δ 4.78-4.72 (dd, 1H), 4.62-4.57 (dd, 1h), 
3.79 (s, 3H), 3.76 (s, 3H), 3.74-3.70 (d, 1H), 2.97-2.94 (m, 1H), 1.90-1.91(m, 1H), 
0.98-0.94 (m, 6H); 13CNMR (400 MHz, CDCl3) δ 169.0, 168.8, 75.6, 53.2, 53.0, 51.5, 
42.8, 29.8, 20.0, 19.4. 
 
Methyl-2-carbomethoxy-3-(nitromethyl)-5-methylhexanoate (7i). The title 
compound can be purified by column chromatography (20% EtOAc/hexanes) to give a 
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colorless oil.  1HNMR (400 MHz, CDCl3) 4.70-4.63 (dd, 1H), 4.53-4.46 (dd, 1H), 3.77 
(s, 3H), 3.76 (s, 3H), 3.63-3.61 (d, 1H), 2.98-2.92 (m, 1H), 1.67-1.61 (m, 1H), 1.31-
1.26 (m, 2H), 0.91-0.87 (m, 6H); 13CNMR (400 MHz, CDCl3) δ 168.6, 168.4, 76.9, 
53.1, 52.9, 52.5, 39.1, 35.1, 25.3, 22.6, 22.4. 
 
Stepwise Synthesis of Pregabalin (3) 
(S)-Methyl-2-carbomethoxy-3-(nitromethyl)-4-methylpentanoate (S-7i). 
Microencapsulated PEI catalyst (1, 250 mg, 11.5 mol %) was swollen in 5 mL 
methanol in a 50 mL glass vessel before use.  S-Nickel catalyst (S-2, 550 mg, 6.8 mol 
%), 3-methylbutyraldehyde (8, 1.63 mL, 15 mmol), nitromethane (5.4 mL, 0.1 mol), 
dimethyl malonate (1.14 mL, 10 mmol), and toluene (25 mL) were added to the 
vessel, which was sealed with a screw cap.  The reaction was rocked at room 
temperature on a rocker for 48 hours.  The µcaps were filtered off by vacuum 
filtration.  The volatile components were removed under reduced pressure and the 
product was purified by column chromatography (20% EtOAc/hexanes) to give 2.46 g 
(94%) of a colorless oil.  Spectral data is given above.  Enantiomeric excess was 
determined by HPLC with a Chiralcel OD-H column (94:6 hexanes:isopropanol, 1.0 
mL/min 215 nm; minor enantiomer tr = 6.5 min, major enantiomer tr = 11.3 min; 72% 
ee. 
 
Methyl 4-isobutyl-2-oxopyrrolidine-3-carboxylate (9).  A solution of (S)-7i (1.05 g, 
5.26 mmol) and 10 mL EtOH was added to a hydrogenation bottle containing Raney 
Ni (0.85 mg, water wet) at room temperature under N2.  The flask was evacuated and 
refilled with hydrogen three times and the reaction was shaken on a Parr 
hydrogenation apparatus at room temperature and 45 psi for 18 hours.  Upon 
completion, the reaction mixture was filtered through Celite 545 and washed with 
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EtOH.  The volatile components were removed under reduced pressure and the 
product was purified by column chromatography (4% MeOH/CHCl3) to give 770 mg 
(96%) of a colorless oil that solidified upon standing.  1HNMR (400 MHz, CDCl3) δ 
7.6 (s, 1H), 3.72 (s, 3H), 3.48-3.42 (t, 1H), 3.05-3.02 (d, 1H), 2.91-2.86 (m, 2H), 1.50-
1.44 (m, 1H), 1.38-1.25 (m, 2H), 0.83-0.78 (m, 6H); 13CNMR (400 MHz, CDCl3) δ 
174.0, 170.6, 55.0, 52.8, 47.1, 43.3, 37.5, 26.1, 22.7, 22.7. 
 
(S)-3-Aminomethyl-5-methyl-hexanoic acid (Pregabalin) hydrochloride (3).  9 (80 
mg, 0.4 mmol) and 5M HClaq (3 mL) were heated at 125 °C for 18 hours.  Upon 
cooling, the mixture was extracted with EtOAC (4 x 10 mL).  The aqueous layer was 
stirred with activated charcoal at 70 °C and filtered through Celite.  The volatile 
components were removed under reduced pressure to give 75 mg (95%) as a white 
solid.  1HNMR (400 MHz, CD3OD) δ 2.95-2.92 (d, 2H), 2.41-2.37-2.28 (d, 2H), 2.21-
2.16 (m, 1H), 1.68-1.61 (m, 1H), 1.24-1.20 (t, 2H), 0.96-0.89 (dd, 6H); 13CNMR (400 
MHz, CD3OD) δ 175.8, 44.5, 41.9, 37.1, 32.5, 26.1, 23.2, 22.4.  For the purposes of 
analysis, the product was converted to the zwitterion by the addition of NaOH so that 
pH = 7.5-8.5 and then recrystallized from isopropanol/water.  The amine was Boc-
protected and the acid converted to the methyl amide as follows: Boc-protection was 
achieved by stirring the zwitterion in the presence of di-tert-butyl dicarbonate, and 
NaHCO3 in a 1:1 mixture of THF:water.23 Amide formation was achieved by 
treatment with methyl amine in the presence of N-methylmorpholine and isobutyl 
chloroformate in THF.18  Enantiomeric excess was determined by HPLC with a 
Chiralcel OD-H column (95:5 hexanes:isopropanol, 0.7 mL/min, 215 nm); minor 




Condensed Synthesis of Pregabalin (3) 
(S)-Methyl-2-carbomethoxy-3-(nitromethyl)-4-methylpentanoate (S-7i). 
Microencapsulated PEI catalyst (1, 250 mg, 11.5 mol %) was swollen in 5 mL 
methanol in a 50 mL glass vessel before use.  S-Nickel catalyst (S-2, 550 mg, 6.8 mol 
%), 3-methylbutyraldehyde (8, 1.63 mL, 15 mmol), nitromethane (5.4 mL, 0.1 mol), 
dimethyl malonate (1.14 mL, 10 mmol), and toluene (25 mL) were added to the 
vessel, which was sealed with a screw cap.  The reaction was rocked at room 
temperature on a rocker for 48 hours.  The µcaps were filtered off by vacuum 
filtration, 1 mL PEI was added to the filtrate, and the mixture was stirred until all of 
the nickel had been chelated, indicated by a color change from green to yellow.  The 
mixture was filtered through celite, the volatile compounds were removed under 
reduced pressure, and the crude product was carried directly to the next step.  The 
remainder of the synthesis was performed as described above to afford 1.68 g (85.7%) 
of (S)-3-aminomethyl-5-methyl-hexanoic acid (pregabalin) hydrochloride (3).  
Spectral data is given above. 
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Exploration of Rate Enhancement in a Nickel-Catalyzed Michael Addition 
 
Preface 
 The multicatalyst system discussed in Chapters 3 and 4 provided us with an 
unexpected result: the microencapsulated amine catalyst for the first step of the 
reaction provided rate enhancement for the second reaction as well.  Though we 
initially attributed this phenomenon to the ureas in the microcapsule shell, we later 
discovered that it was, in fact, due to the amines.  This chapter discusses our 




 The rate of the Michael addition between trans-β-nitrostyrene and dimethyl 
malonate was found to be enhanced in the presence of a polyurea-encapsulated 
polymeric amine.  This rate enhancement was determined to be due to the 
encapsulated amine groups, and it was discovered that the amine and the nickel-based 
Michael addition catalyst form a catalyst complex.  Kinetic models and experiments 
suggest that the complex is composed of a 2:1 amine-to-nickel ratio and that the 
reaction is half-order in complex.  The effects of the amine on the selectivity of the 
Michael reaction is discussed. 
 
Introduction 
Chemists have long realized the advantage of using multiple catalysts in a 
single process.1  Early examples are found predominantly in the field of polymer 
synthesis, most notably in reactions such as Ziegler-Natta chain transfer 
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polymerization.2  Defined here as co-catalysis, these multicatalyst systems require the 
presence of a second species to activate or regenerate the catalytic species.  The 
continued desire for more efficient and selective chemistry has led to the application 
of new types of multicatalyst systems to small molecule synthesis.  Tandem catalysis, 
for example, involves the performance of two reactions in the same flask, each 
catalyzed by a different catalyst.  Dual catalysis, on the other hand, involves the 
presence of a species that increases the rate of a single reaction, but unlike co-
catalysis, the presence of the additive is not required for catalysis to proceed.  The 
value of placing catalysts together is therefore multifold; this strategy can result in 
more reactions per vessel, as in tandem catalysis, or in single reactions with faster 
rates or more selective outcomes, as in dual or co-catalysis. 
These early ideas are being extended to small molecule synthesis, where the 
use of a second species to activate either the catalyst or substrate has resulted in faster 
or more selective reactions.  In a 1999 review, Shibasaki et al. outlined cases in which 
amines, N-oxides, alcohols, phosphine oxides, and ionic species enhanced the yields 
and enantioselectivities of transition metal-based reactions.3  Miller et al. continued by 
demonstrating that a non-transition metal dual amine system effectively promoted 
asymmetric Baylis-Hillman reactions.4  More recently, Yamamoto reviewed systems 
where dual Brønsted and Lewis acid catalysts are used to effectively promote new and 
faster reactions.5  This growing field of work highlights the advantages of combining 
two catalysts in a single reaction and shows promise for the development of faster and 
more selective chemistry. 
In Chapters 3 and 4, we discussed a multicatalyst system that 
enantioselectively forms a Michael adduct from an aldehyde, a nitroalkane, and a 
malonate ester (Scheme 5.1).  The first step of this tandem reaction employs 
microencapsulated poly(ethyleneimine) (PEI) as a catalyst for nitroalkene formation, 
 84 
while the second step involves a nickel-mediated Michael addition.  Furthermore, we 
showed that in addition to catalyzing the first step, the microencapsulated catalyst 
enhanced the rate of the second step as well.  Determining the origin of this rate 
enhancement, as well as understanding the interactions between the microencapsulated 
catalyst and the nickel catalyst, would be beneficial for designing other dual catalytic 
systems.  In this work, we investigate the origin of rate enhancement and examine the 
kinetics of this dual catalysis in order to better understand our system. 
 
 
Scheme 1.  Dual catalyst system catalyzed by an encapsulated amine (1) and a nickel-
based catalyst (2).   
 
Results and Discussion   
 In order to investigate the rate enhancement for the Michael addition discussed 
in Chapter 4, we examined a series of polymeric and small-molecule ureas.  The 
polyurea shell of the microencapsulated catalyst 1 is represented in Figure 5.1.  We 
looked at diphenyl urea (4) and ethyl phenyl urea (5) as simple urea analogs, as well as 
a polymeric urea (6) formed by the condensation of poly(methylene (polyphenyl) 
isocyanate) (PMPPI) and tetraethylenepentamine (TEPA).  When tested in the Michael 
addition between trans-β-nitrostyrene and dimethyl malonate (DMM), however, no 




Figure 5.1.  Small-molecule and polymeric ureas. 
 
 We then prepared more direct analogs of the polyurea shell of 1 in order to 
determine the origin of the observed rate enhancement.  A polymeric version (7) was 
prepared by the condensation of free PEI with phenyl isocyanate, while a small 
molecule analog (8) was synthesized from N,N-dimethylethylenediamine and phenyl 
isocyanate (Figure 5.2).  Both 7 and 8 increased the rate of the Michael addition, 
indicating that these analogs do contain the feature responsible for the rate 

















Figure 5.2.  Small-molecule and polymeric analogs of the polyurea shell of 1. 
 
 While precedent exists for the unique activity of bifunctional ureas,6-9 we could 
not rule out the possibility that the observed rate enhancement is due to the amine 
alone.  To isolate the effects of the amine and the urea, we investigated the amide 
versions of the urea analogs shown in Figure 5.2, as well as simple small molecule 
amines (Figure 5.3).  The rate enhancement provided by each of these amines 
indicated, along with the observation that none of the ureas shown in Figure 5.1 
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affected the rate of the Michael indicated that the amine, not the urea, is responsible 















Figure 5.3.  Small-molecule and polymeric amines. 
 
Having determined that the increased rates provided by 1 were due to amines 
rather than ureas, we next sought to establish the specific origin of the rate 
enhancement, as both the microcapsule shell and the encapsulated PEI contain tertiary 
amines that may be capable of providing the observed rate enhancement.  Because we 
showed in Chapter 3 that nickel catalyst 2 is able to function in the presence of PEI, it 
is possible that the rate enhancement is imparted by the encapsulated amines rather 
than the shell itself.  An interesting observation is that although rate enhancement of 
the Michael addition is observed in the presence of swollen acylated µcaps (Figure 
5.4), no enhancement is observed if the µcaps are not swollen.  An explanation 
consistent with shell amine-enhancement is that the geometry of the crenated shell 
does not allow access to the amines of the capsule wall.  However, an alternate 
explanation is that the reagents and catalyst for the Michael addition cannot access the 
encapsulated PEI if the capsules are not swollen.  This is consistent with the 
observation that nitroalkene formation does not occur in the presence of unswollen 
µcaps because the catalytic amines are not accessible.  Though both of these 
explanations are plausible, the absence of rate enhancement with amine-containing 
µcaps 6 suggests that the shell amines of both 6 and 1 may both be incapable of 
accelerating the reaction.  Though further experiments are necessary to conclusively 
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demonstrate that the rate enhancement is due to the amines of the encapsulated PEI 
rather than the shell itself, preliminary evidence suggests that this is the case. 
 
 
Figure 5.4.  Michael addition in the presence (●) and absence (○) of unswollen 
acylated microcapsules. 
 
Kinetic Studies.  In order to gain more insight into the role of amine in the 
Michael addition, we carried out kinetic studies.  Because much of this work was done 
before the discovery that the rate enhancement is due to the amine rather than the urea, 
the data here is presented here using bifunctional urea 8 but will be referred to as 
“amine 8.”  For cases in which the experiments presented below were repeated using 
amine 11 in place of 8, the results were consistent with each other, indicating that this 
substitution is valid.  Instead of finding the reaction to be first order in both 8 and 2 as 
we expected from the data shown in Chapter 4, however, we found that the reaction 
was not first order in either. Instead, although at low concentrations of 8, the reaction 
appeared to be first order in amine, the order plot loses linearity at higher 




Figure 5.5.  Order in amine 8, 2% nickel catalyst 2. 
 
 The order plot for nickel catalyst 2 produced unexpected results as well.  With 
no amine present, the data indicated that the Michael addition was first order in 2, 
which is consistent with previously reported results.10  However, in the presence of 
amine 8, the reaction was no longer first order in 2.  For a variety of concentrations of 
8 (Figure 5.6 and Supporting Information), the order plots for 2 exhibited curvature.  
When fitted to a y = mxb plot, these plots did not produce consistent results for the 
order in 2, making it unlikely that the reaction is half or other partial order in 2. 
 
 
Figure 5.6.  Order in nickel catalyst 2, 10% (●), 3.5 % (○), and 0 % () amine 8. 
 
 Unable to fit the data for either 8 or 2 to any particular order, we wondered if 
the two catalysts were not acting independently, but instead forming a complex that 
itself catalyzed the Michael addition.  To address this possibility, we created a model 
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to see whether we could predict our experimental results theoretically.  In creating the 
model, we made the following assumptions.  The reaction can proceed via two 
different pathways: one catalyzed by the complex, and one catalyzed by nickel catalyst 
2 (Eq. 5.1).  Assigning the rate constants k1 and k2, respectively, the rate of formation 
of 3 can be written as 
    
d[3]/dt = k1[2•8][NS][DMM] + k2[2][NS][DMM]        (Equation 5.1) 
 
where “2•8” refers to the complex, “NS” to trans-β-nitrostyrene, and “DMM” to 
dimethyl malonate.  Because we are interested only in the initial rate of the reaction, 
the rate expression can be simplified to Equation 5.2. 
 
d[3]/dt = k1[2•8] + k2[2]                     (Equation 5.2) 
 
A second assumption is that the free catalysts 2 and 8 are in equilibrium with catalyst 
complex 2•8. Assuming that 2 and 8 form the complex in a 1:1 ratio, the equilibrium 









where x represents the amount of complex 2•8 formed from 2 and 8.  Equation 5.4 can 
be solved in terms of x (see Supporting Information).  By choosing appropriate values 
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for k1, k2, and Keq, Equations 5.2 and 5.4 can be used to create order plots for the 
Michael addition. 
 In assigning the rate constants for the model, we assumed that k1 > k2 due to 
the rate enhancement that is observed in the presence of amine 8.  Keq, on the other 
hand, was chosen arbitrarily, as we had no insight into where the equilibrium lay.  
Figure 5.7 shows the results of models for which Keq = 0.01 (a and b) and Keq = 5 (c 
and d).  For both cases, k1 = 5 and k2 = 0.1.  It is evident that only the first graph for 
order in amine (Figure 5.7a) produces data that is similar to the experimental results.  
However, since the corresponding order in nickel graph (Figure 5.7b) is not consistent 
with our observations, it is unlikely that the model is valid. 
 
 
Figure 5.7.  Order plots constructed from Equations 5.2 and 5.4, k1 = 5.0, k2 = 0.1. (a) 
order in amine, nickel = 3, Keq = 0.01; (b) order in nickel, amine = 3.5, Keq = 0.01; (c) 
order in amine, nickel = 3, Keq = 5.0; (d) order in nickel, amine = 3.5, Keq = 5.0. 
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 The discrepancies between our experimental and theoretical results prompted 
us to reexamine the assumptions we made in our model.  The most likely explanation 
for why our data did not fit our model is that we did not understand the nature of the 
catalyst complex, i.e., the ratio of nickel catalyst to amine was not 1:1.  Faced with this 
possibility, we attempted to determine the stoichiometry of the complex in a number 
of ways.  Co-crystallization of the nickel catalyst with amine 8 (or amine 11) did not 
result in crystallization of the complex.  In addition, 1H NMR observation of the nickel 
and amine at various ratios were unhelpful, as they did not reveal any evidence of a 
catalyst complex.  Unable to isolate and characterize the complex, we turned to the 
method of continuous variation to construct a Job plot.  Often used to determine 
binding stoichiometry, the method of continuous variation monitors the change in a 
chosen response when the ratio of two interacting components are varied while 
keeping their total concentration constant.11-12  The maximum on the response curve 
indicates the binding stoichiometry of the two components.  We constructed a Job plot 
using nickel catalyst 2 and amine 8 in hopes that it would give us information about 
the stoichiometry of the catalyst complex.  Keeping the total catalyst concentration 
constant at 2 mol %, we varied the ratio of 2:8 and monitored the rate of reaction.  The 
Job plot shown in Figure 5.8 is representative of the results of experiments carried out 
over a range of total reaction concentrations (see Supporting Information), and it 




Figure 5.8.  Job plot, 2% total catalyst concentration. 
 
 With more insight into the nature of the catalyst complex 2•8, we revised our 
model as follows.  Instead of assuming a 1:1 catalyst ratio, Equation 5.5 is the 







which can again be solved for x (see Supporting Information). 
 When we used these modified equations in our rate model, we again found that 
the results did not correspond well with our experimental data (Figure 5.9).  For this 
model, the amine and nickel appeared second order and first order, respectively.  On 
the other hand, the experimental results resembled to first and partial order.  These 
observations suggested that rather than being first order in complex, the reaction might 
be half-order in complex, with the corresponding rate expression shown in Equation 
5.7.  
 




Figure 5.9.  Order plots constructed from Equations 5.2 and 5.6, k1 = 5.0, k2 = 0.1, Keq 
= 0.01. (a) order in amine, nickel = 3; (b) order in nickel, amine = 3.5.  See 
Experimental Section for reaction conditions. 
 
When the reaction was modeled as half order in catalyst complex, we found 
that the theoretical results that we obtained matched our experimental results quite 
well.  The order plot for amine appears to be first order at low amine concentrations 
but lower order at high concentrations (Figure 5.10a), while the order plot for the 
nickel catalyst exhibits the same curvature that is seen in Figure 5.6 (Figure 5.10b).  
These results suggested that the data we obtained from our Job plots was valid, and 




Figure 5.10. Order plots constructed from Equations 5.6 and 5.7, k1 = 5.0, k2 = 0.1, 
Keq = 0.01. (a) Order in amine, nickel = 3; (b) order in nickel, amine = 10 (●), 3.5 (○), 
1 (). 
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To verify our model, experimentally, we constructed an order plot for the 
catalyst complex by varying the catalyst concentrations while keeping them in a 2:1 
ratio.  Although it is not possible to know the absolute amount of complex in solution 
without knowing the equilibrium constant, its concentration will vary in proportion to 
its individual constituents.  Depending on the values of Keq, and the relative values of 
k1 and k2, we expected to obtain an order in complex between 0.5 and 1.0, since the 
observed rate will be the result of the half-order complex-catalyzed pathway and the 
first order nickel-catalyzed pathway.  Furthermore, the order in complex should be 
closer to 0.5 than 1.0, since the reaction is dominated by the complex-catalyzed 
pathway.  Indeed, Figure 5.11 shows that the apparent order in complex is 0.59, 
consistent with our expected results.   
 
 
Figure 5.11. Michael addition order in catalyst complex, amine-to-nickel ratio of 2:1. 
 
 Our theoretical and experimental results indicate that the Michael addition is 
catalyzed by a 2:1 amine-to-nickel complex and that the reaction is half order in this 
complex.  However, the physical meaning of these results is currently unknown.  More 
experiments are necessary to determine why this reaction is half-order in complex, but 
the results discussed above provide us with preliminary evidence that is crucial to 
better understanding this dual catalyst system. 
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 Selectivity Studies.  With a better understanding of the interaction between the 
nickel catalyst and amine, we turned our focus toward the impact of the amine on the 
selectivity of the Michael addition.  Since the catalyst complex is in equilibrium with 
its individual components, increasing the initial concentration of either one of the 
components would result in the increase in complex concentration.  Since the nickel 
catalyst synthesis is relatively resource- and time-consuming, the ability to increase 
the rate of the reaction by the addition of an inexpensive, commercially available 
amine is appealing.  However, we noticed that the enantioselectivity of the one-pot 
reaction in the synthesis of pregabalin was lower than the selectivity of the Michael 
addition reported by Evans et al.10 and wondered how the selectivity changed in 
response to the presence of various amounts of amine.  Figure 5.12 shows the ee of 
product 3 when the nickel catalyst loading was kept constant and the amine loading 
was varied. The closed open and closed circles represent nickel catalyst loadings of 
0.5 and 2.0%, respectively, indicating that change in selectivity is a result of amine-to-
nickel ratio rather than overall catalyst concentration.  The addition of more amine 
results in a faster reaction due to in increased concentration of catalyst complex, but it 




Figure 5.12.  Selectivity of the Michael addition with various amine loadings at 0.5 
mol % (●) and 2 mol % (○) nickel catalyst 2. 
 
 In an attempt to recover the selectivity that is lost due to increased amine 
loadings, we performed the Michael addition at lower temperatures at a variety of 
amine-to-nickel ratios.  Surprisingly, we found that for all cases in which the amine 
was present, when the temperatures were lowered, the selectivies decreased (Figure 
5.13).  On the other hand, when the reactions were performed at elevated 
temperatures, the selectivities initially increased before decreasing when the 
temperatures were increased further.  This effect was observed in both chloroform and 
toluene, though the specific response to the change in temperature varied between the 
two solvents.  This unexpected result may be due to a preferential increase of the rate 
of the nickel-catalyzed pathway over the complex-catalyzed pathway elevated 
temperatures, resulting in catalysis via the more selective route.  This hypothesis could 





Figure 5.13. Selectivity of the Michael addition with 2 mol % 2 at various 
temperatures in chloroform (a) and toluene (b).  8:2 =  0 (●), 0.5 (○), 2.0 (), 5.0 (). 
 
 The increased selectivities at elevated temperatures in the presence of the 
amine suggested that we could perform the reaction at reduced catalyst loadings while 
still obtaining reasonable reaction rates.  By raising the temperature, we expected to 
obtain higher rates and selectivities compared to room temperature in the presence of 
the amine.  Indeed, the selectivites for the Michael addition performed at 50 oC with 
0.2 mol % nickel catalyst 2 were virtually the same in the absence and presence of 0.1 
mol % amine 11 (92.6% and 92.3%, respectively).  However, at these low loadings, 
the rate enhancement imparted by the amine was minimal (Figure 5.14), exhibiting a 
krel of only 1.77 and reducing the reaction time by merely one hour.  Although under 
these conditions, the amine does provide modest rate enhancement while maintaining 
good enantioselectivities, the effects of the amine additive are as not as beneficial as 




Figure 5.14.  Michael addition at 50 oC, 0.2 mol % nickel catalyst loading, 0.1% (●) 
and 0% (○) amine 11. 
 
Conclusion 
 We have shown that the rate enhancement provided by our microencapsulated 
amine catalyst is due to the encapsulated amines rather than the polyurea shell.  
Kinetic studies suggested that rather than acting independently, the two catalysts form 
a complex in a 2:1 amine-to-nickel reaction.  Furthermore, this dual-catalyst system 
behaves unexpectedly in response to temperature changes, providing increased 
selectivity at elevated temperatures.  Although these results taken together showed 
promise for performing rapid Michael additions at reduced catalyst loadings, in 
practice, the low amine loadings required for high selectivities were not able to effect 
considerable rate enhancement.  However, the discoveries that we made have provided 
us with a better understanding this dual-catalytic system, and will aid us as we 





 This work concludes a four-year project that began the day I joined the 
McQuade group and was asked to develop a multicatalyst system for the synthesis of 
pregabalin.  Not surprisingly, this project, while resulting in a successful multicatalyst 
reaction, led us in unexpected directions, including the investigation of the phase 
behavior inside the microcapsules (Muris Kobašlija) as well as the work discussed in 
this chapter.  It also prompted us to look at ureas as potential partners in multicatalyst 




All reagents were used without purification unless otherwise noted.  Ethyl 
phenyl urea was recrystallized from ethyl acetate, trans-β-nitrosobenzene was 
recrystallized from ethanol, and dimethyl malonate was distilled under vacuum prior 
to use.  Gas chromatographic (GC) analyses were performed using a Varian CP-3800 
GC equipped with a Varian CP-8400 autosampler, a flame ionization detector (FID) 
and a Varian CP-Sil 5CB column (length = 15 m, inner diameter = 0.25 mm, and film 
thickness = 0.25 µm.  The temperature program for GC analysis held the temperature 
constant at 80 ºC, heated samples from 80 to 200 ºC at 17 ºC/min, and held at 200 ºC 
for 2 min.  Inlet and detector temperatures were set constant at 220 and 250 ºC, 
respectively. Mesitylene was used as an internal standard to calculate reaction 
conversion.  Alternatively, GC analyses were performed using an Agilent 7890A GC 
equipped with an Agilent 7683B autosampler, a flame ionization detector (FID), and a 
J&W Scientific 19091J-413 column (length = 30 m, inner diameter = 320 µm, and 
film thickness = 250 µm).  The temperature program for GC analysis held the 
temperature constant at 80 oC for 1 min, heated samples from 80 to 200 oC at 25 
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oC/min and held at 200 oC for 1.5 min.  Inlet and detector temperatures were set 
constant at 250 and 300 oC, respectively.  1H NMR and 13C NMR spectra were 
recorded on a Varian Inova-400 (400 MHz) spectrometer and are reported in ppm 
using solvent as an internal standard (CDCl3 at 7.26 ppm).  Data are reported as s = 
singlet, d = doublet, t = triplet, quin = quintet, m = multiplet.  High performance liquid 
chromatography (HPLC) was performed using a Varian Pro Star chromatograph using 
a CHIRALPAK IA column (250 mm x 4.6 mm) and CHIRALPAK IA guard column 
(1 cm x 0.4 cm).  All chromatograms were obtained using a wavelength of 254 nm. 
 
Synthesis of Microencapsulated Poly(ethyleneimine) Catalyst (1).  The catalyst 
was prepared as described in the Experimental Section of Chapter 3. 
 
Synthesis of PMPPI caps (4).  All compounds were deoxygenated prior to 
encapsulation.  To a 250 mL Erlenmeyer flask was added an aqueous solution of 
poly(vinyl alcohol) (150 mL, 0.5% w/w in DI H2O, Mw = 89,000-98,000, 99+% 
hydrolyzed).  The organic phase, consisting of CHCl3 (17 mL) and poly(methylene 
(polyphenyl) isocyanate) (3 mL, 1 equiv isocyanate, 30% incorporation) was dispersed 
in the aqueous phase using an IKA Ultra-Turrax T25 homogenizer at 6500 rpm for 2 
min.  The resulting emulsion was stirred gently.  After stirring for 5 minutes, a second 
aqueous phase consisting of tetraethylenepentamine (100 µL, 0.17 equiv) in a solution 
of poly(vinyl alcohol) (20 mL) was added to the emulsion via syringe. The emulsion 
was allowed to stir gently overnight.  The resulting microcapsules were isolated by 
centrifugation and washed with DI H2O (2 x 200 mL), EtOH (2 x 200 mL), and Et2O 
(1 x 100 mL).  The microcapsules were dispersed in Et2O (100 mL), transferred to a 
250 mL round-bottom flask, concentrated by rotary evaporation, and dried under 
vacuum to yield a free-flowing powder. 
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Preparation of 5.  PEI (MW = 10,000, 1 g, 5.81 mmol 1o amines) was dissolved in 
CHCl3 (10 mL).  Phenyl isocyanate (0.63 mL, 5.81 mmol) was added at slowly, 
resulting in the formation of a white precipitate.  The reaction was stirred for 15 min 
and the polymer was washed with CHCl3 and dried under vacuum to provide the 
polymeric urea 5. 
 
1-(2-(dimethylamino)ethyl)-3-phenylurea (6).  Phenyl isocyanate (1.08 mL, 10 
mmol, 1 eq) was added dropwise to a solution of N,N-dimethylethylenediamine (1.1 
mL,10 mmol, 1 eq) in CHCl3 (10 mL) at room temperature and the reaction was 
stirred for 30 min.  The solvent was removed in vacuo and the product was 
recrystallized from EtOAc to afford white crystals (1.8 g, 87%).  1H NMR (300 MHz, 
CDCl3) δ 7.35 (d, 2H), 7.22 (t, 2H), 6.97 (t, 1H), 6.36 (t, 1H), 3.30 (q, 2H), 2.42 (t, 
2H), 2.12 (s, 3H); 13C NMR (75 MHz, CDCl3) δ 157.8, 139.9, 129.2, 122.7, 120.0, 
60.1, 45.5, 38.7. 
 
Preparation of 7.  PEI (MW = 750,000, 50 wt% solution in water, 1.9 g, 5.52 mmol 
1o amines) was dissolved in MeOH (10 mL).  The solution was cooled to -78 oC and 
acetyl chloride (0.78 mL, 11.0 mmol) was added dropwise.  The reaction was removed 
from the cold bath and was stirred at room temperature for 16 h.  The solvent was 
removed in vacuo and the acylated polymer was dialyzed against H2O (pH = 11) for 8 
h, and H2O (pH = 7) (2 x 8 h).  The solvent was removed in vacuo to provide the 
acylated polymer 7. 
 
N-(2-(dimethylamino)ethyl)ethanamide (8).  Acetyl chloride (1.4 mL, 20 mmol, 2 
eq) was added dropwise to a solution of N,N-dimethylethylenediamine (1.1 mL,10 
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mmol, 1 eq) in CHCl3 (5 mL) at -78 oC and the reaction was stirred for 2 h at -78 to 25 
oC.  The solvent was removed in vacuo and the product was chromatographed (silica 
gel, 96:4 CHCl3:MeOH) to afford a light yellow oil (1.2 g, 92%). 1H NMR (300 
MHz, CDCl3) δ 6.41 (br, 1H), 3.22 (m, 2H), 2.32 (t, 2H), 2.16 (s, 6H), 1.94 (s, 3H); 
13C NMR (75 MHz, CDCl3) δ 170.3, 57.9, 45.1, 36.9, 32.2. 
 
General procedure for determination of rate enhancement.  To trans-β-
nitrostyrene (149.2 mg, 1 mmol), nickel catalyst 2 (16.2 mg, 0.02 mmol), and 
mesitylene (13.9 µL, 0.1 mmol) in solvent (1 mL) was added the appropriate polymer, 
urea, or amine.  Dimethyl malonate (137.1 µL, 1.2 mmol) was added and the reaction 
was stirred at room temperature.  Reaction conversion was monitored by withdrawing 
aliquots from the reaction at different time intervals, diluting with methylene chloride, 
and analyzing by GC with reference to mesitylene.  See Supporting Information for 
full conditions and results. 
 
Acylation of encapsulated amines. To microcapsule catalyst 1 (100 mg), loaded in a 
syringe equipped with a frit, methanol (5 mL) was added to swell them.  After 5 
minutes the excess methanol was removed and the solution containing acetic 
anhydride (1 mL) in methanol (5 mL) was drawn into the syringe.  The mixture was 
rocked at room temperature overnight.  The acylated microcapsules were extensively 
washed with methanol and dried in vacuo. 
 
Michael addition in the presence of acylated microcapsules.  To trans-β-
nitrostyrene (149.2 mg, 1 mmol), nickel catalyst 2 (16.2 mg, 0.02 mmol), acylated 
microcapsules (15 mg), and mesitylene (13.9 µL, 0.1 mmol) in toluene (1 mL) was 
added dimethyl malonate (137.1 µL, 1.2 mmol) and the reaction was stirred at room 
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temperature.  Reaction conversion was monitored by withdrawing aliquots from the 
reaction at different time intervals, diluting with methylene chloride, and analyzing by 
GC with reference to mesitylene. 
 
General procedure for kinetic studies.  To trans-β-nitrostyrene (149.2 mg, 1 mmol), 
mesitylene (13.9 mL, 0.1 mmol), and the appropriate amounts of nickel catalyst 2 and 
amine 8 in chloroform was added dimethyl malonate (137.1 µL, 1.2 mmol) and the 
reaction was stirred at room temperature.  Reaction conversion was monitored by 
withdrawing aliquots from the reaction at different time intervals, diluting with 
methylene chloride, and analyzing by GC with reference to mesitylene.  See 
Supporting Information for full conditions and results. 
 
Supporting Information 
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Using Bifunctional Ureas to Increase the Rate of Proline-Catalyzed α-Aminoxylations 
 
Preface 
 Before we discovered the rate enhancement for the Michael addition was 
provided by the amine and not the urea, my adviser asked me to find a proline-
catalyzed reaction that would potentially benefit from electrophile activation.  In the 
last few days before packing up the lab and moving it to Tallahassee, I stumbled 
across the α-aminoxylation of aldehydes, as it was one of the few proline-catalyzed 
reactions for which we had all of the reagents on hand.  Rate enhancement was indeed 
observed in the presence of our bifunctional urea, and further investigation upon 
arriving at Florida State University led to even more unexpected results.  
 
Abstract* 
The rate of the proline-catalyzed α-aminoxylation of aldehydes is significantly 
increased in the presence of a bifunctional urea.  Structure-activity relationship data 
indicates that both an amine and urea are crucial for rate enhancement.  The evidence 
presented herein suggests that this rate enhancement originates from hydrogen 
bonding interaction between the bifunctional urea and an oxazolidinone intermediate 
to increase the rate of enamine formation.  Proline derivatives that are incapable of 
forming oxazolidinones exhibit no rate enhancement in the presence of the 
bifunctional urea.  The rate enhancement is general for a variety of aldehydes, and the 
faster reactions do not reduce yields or selectivities. 
                                                
* Reproduced with permission from: Poe, S. L.; Bogdan, A. R.; Mason, B. P.; 
Steinbacher, J. L.; Opalka, S. M.; McQuade, D. T. J. Org. Chem. 2008, submitted. 
Copyright 2008 American Chemical Society. 
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Introduction 
The field of organocatalysis is comprised of many catalyst classes that enable 
an expanding range of selective transformations.1-3  Though amine-based catalysts 
were some of the first organocatalysts to be explored, interest in them remains strong 
because they offer enamine, iminium ion, and SOMO mechanisms that provide a wide 
range of highly enantioselective reactions.4,5  Proline alone, one of the most widely-
used organocatalysts, catalyzes transformations ranging from aldol condensations and 
Mannich reactions to Diels-Alder reactions, and many proline derivatives are also 
effective catalysts.6-9  Though proline catalysis is quite versatile, limitations exist, 
including the need for high catalyst loadings and excess reagents, slow reaction rates, 
complex reaction kinetic profiles, and the use of unfavorable solvents.10,11  These 
obstacles limit the application of proline-based catalysis, and a new strategy is 
required to exploit its full potential in both academic and industrial settings.  
In the past five years, the proline-catalyzed α-aminoxylation of aldehydes and 
ketones with nitrosobenzene has received attention because it provides an effective 
route to α-hydroxy carbonyl species.12-18  Initially reported in 2003 by the groups of 
both Zhong and MacMillan, this reaction was believed to proceed through a 
mechanism consistent with standard enamine catalysis, involving the formation of an 
enamine in a pre-equilibrium step followed by reaction with nitrosobenzene.  
However, subsequent work has revealed that α-aminoxylation exhibits unusual kinetic 
behavior that is not observed in typical proline catalysis.  Detailed studies by 
Blackmond and coworkers have shown that this reaction displays autoinduction that 
cannot be attributed to simple proline dissolution.19-23  Instead, they propose a model 
in which a product-proline complex is formed and converted directly to the enamine, 
allowing for a faster pathway that circumvents free proline.  In addition, independent 
work by Seebach et al. has addressed the oxazolidinone species that have been 
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observed in proline-catalyzed reactions, and has shown evidence for their role as 
productive intermediates in enamine formation.24  Taking this into account, we 
provide a modified version of the catalytic cycle put forth by Blackmond, which is 
proposed to proceed via rate-limiting enamine formation before entering a faster 
catalytic cycle in which exchange between the product-proline complex D and the 
enamine B becomes rate determining (Scheme 6.1).22,23 
 
 
Scheme 6.1. A Blackmond et al.-inspired catalytic cycle for the α-aminoxylation of 
aldehydes.  Observed autoinduction is justified by the emergence of an alternate 
pathway (dashed lines) that is mediated by the product-proline complex D. 
 
Although the α-aminoxylation of aldehydes is much more rapid than other 
proline-catalyzed reactions, it does suffer from drawbacks such as byproduct 
formation and generally high catalyst loadings.10,11  Accelerating the rate-limiting 
enamine formation would result in a faster overall reaction and potentially mitigate or 
eliminate such problems.  Furthermore, the reported optimal solvents for the α-
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aminoxylation of aldehydes are chloroform and DMSO, which are environmentally 
unfavorable.  A faster reaction would enable the use of greener solvents that might 
otherwise provide a slow or unproductive reaction.  In addition, perturbation of any of 
the steps along this complex reaction pathway may help to elucidate some of its 
mechanistic features.  Inspired by the recent work that has successfully used additives 
such as amines, water, and diols to improve the proline-catalyzed aldol reaction,25 we 
sought to identify an additive that could provide similar enhancements for the α-
aminoxylation.  If successful, it is possible that the rate enhancement might be 
extended to other proline-catalyzed reactions as well.  We initially explored the use of 
bifunctional ureas in the α-aminoxylation of aldehydes due to the wide body of recent 
work suggesting that ureas activate carbonyl species by lowering the LUMO of the 
electrophile.26-29  In addition to the potential for activating the aldehyde toward attack 
by proline, it has been shown that ureas with tethered Lewis bases can aid 
deprotonation, which would further enhance the formation of the activated enamine 
species.30-32  Herein, we demonstrate that a bifunctional urea significantly increases 
the rate of α-aminoxylation while maintaining high yields and enantioselectivities, and 
we discuss the origin of the observed rate enhancement. 
 
Results and Discussion 
Rate Enhancement and Structure-Activity Relationship Study.  
Bifunctional urea 1 was prepared from phenyl isocyanate and N,N-
dimethylethylenediamine to obtain a compound consisting of both a urea and a tertiary 
amine.  We examined the α-aminoxylation of hexanal in chloroform, shown by 
MacMillan12 to produce high yields and enantioselectivities, as well as in ethyl 
acetate, a solvent that is more environmentally benign but that has not yet been shown 
to be a suitable solvent for this reaction.33  As seen in Table 6.1 (entries 1, 3 and 4, 6), 
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the presence of urea 1 significantly increases the rate of α-aminoxylation in both 
solvents.  The effect of 1 is especially pronounced when the reaction is performed in 
ethyl acetate; though product 5a was undetectable after 40 minutes for the proline-
only case, the presence of urea 1 results in a yield of over 80% in the same amount of 
time.  The acceleration that we observe for both solvents suggests that 1 enhances the 
rate-determining enamine formation.  
To investigate the origin of the observed rate enhancement, we performed a 
structure-activity relationship study with a series of ureas, amines, and amides (Figure 
6.1).  When examined individually, each of these functional groups provided only 
modest rate enhancement (Table 6.1, entries 7-9).  Furthermore, the combination 1-
ethyl-3-phenylurea (2) and N,N-dimethylethylamine (3, Table 6.1, entry 10) does not 
reproduce the rate enhancement that is observed with 1, strongly suggesting that the 
proximity of the urea and amine is significant.  Interestingly, although thioureas have 
been shown to be more effective hydrogen bond donors than their urea counterparts,34 
















































Entry Additive Solvent Time (min) Yield 5a (%)a ee (%) 
1 no additive CHCl3 5 5 99 
2 1, no proline CHCl3 5 NR - 
3 1 CHCl3 5 96 99 
4 no additive EtOAc 40 <1 98 
5  1, no proline EtOAc 40 NR - 
6 1 EtOAc 40 81 98 
7 2 EtOAc 40 3 98 
8 3 EtOAc 40 2 >99 
9 4 EtOAc 40 2 >99 
10 2 + 3 EtOAc 40 7 >99 
aYields based on calibrated GC data. 
 
Scope.  To show that the rate enhancement provided by bifunctional urea 1 
does not come at the cost of degraded yields and enantioselectivities, we performed 
the α-aminoxylation on a range of aldehydes in ethyl acetate (Table 6.2).35  The 
excellent to moderate yields and excellent enantioselectivities that were obtained with 
the proline-urea system are similar to those observed by others using proline only.  
Because the presence of urea increases the rate but does not alter yields or selectivities 
of this reaction, we suggest that it serves only to facilitate enamine formation and does 
not impact the selectivity-determining step.  If the urea did influence the selectivity-
determining step we would expect changes in the enantioselectivity and alterations in 




















Entry R Product Time (h) Yielda (%) ee (%) 
1 nBu 5a 2 96 99 
2 Me 5b 3 90 98 
3 iPr 5c 3.5 97 99 
4 nhex 5d 5 84 99 
5 CH2Ph 5e 3.5 84 >99 
6 Ph 5f 2 55 99 
7 CH2CH=CH2 5g 2.5 75 99 
aDue to the instability of the aldehyde, O-addition products were reduced to their 
corresponding 2-aminoxy alcohols prior to isolation. 
 
Catalyst Loading.  The increased reaction rates we observed with urea 1 
prompted us to investigate the potential for decreased catalyst loadings.  The solubility 
of proline in many organic solvents is low, and the conditions at the beginning of the 
reaction are saturating in proline. However, the α-aminoxylation reaction becomes 
homogeneous as the reaction proceeds, indicating that proline becomes soluble as the 
reaction progresses.36  We looked at catalyst loadings of 0.5, 1.0, and 2.5 mol %, 
where [proline] = [urea], and compared the results with the proline-only controls.  As 
expected, the rates of both the proline-only and proline-urea cases changed in response 
to changes in catalyst loading (Figure 6.2).  In addition, all cases displayed significant 
rate enhancement when the urea was present, with the 2.5% and 1% catalyst loadings 
resulting in yields of 97% and 91%, respectively.  As the loadings were progressively 
lowered and the reactions became slower, yields suffered as the oxidant began to 
decompose faster than it reacted with the enamine (Figure 6.2c).  It should, however, 
be noted that none of the proline-only cases achieved yields above 50% due to this 
decomposition, highlighting the value of urea 1 in these reactions.  The results seen in 
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Figures 6.2a and 6.2b suggest the potential for additives such as 1 to enable reactions 
with even lower catalyst loadings, especially those that do not suffer from 
decomposition or byproduct formation. 
 
 
Figure 6.2. Reaction profiles for the α-aminoxylation of hexanal with a) 2.5% proline, 
b) 1% proline, and c) 0.5% proline.  Urea concentration varies as follows: [urea] = 
[proline] (●), no urea (○). 
 
Extension to the Mannich Reaction.  As suggested above, accelerating the 
rate of enamine formation may have implications for other proline-catalyzed reactions 
involving rate-determining enamine formation.  When urea 1 was employed in the 
Mannich reaction between benzaldehyde N-Boc imine and propionaldehyde, a faster 
reaction was observed in comparison to the proline-only case while the yields and 
selectivities of product 6 were left unchanged (Scheme 6.2).  A structure-activity 
relationship revealed that as for the α-aminoxylation, using urea 2 or amine 3 
individually in place of 1 did not provide as great an enhancement, but in this case, the 
combination of 2 and 3 were able to reproduce the enhancement provided by 1 (see 
Supporting Information).  The reasons for this difference are currently unknown, but 
in any case, because urea 1 provides rate enhancement in this reaction as well as in the 
α-aminoxylation, it is possible that the increase in the rate of enamine formation may 




NBoc L-proline (20 mol%)





with 1: 2.5 h, 
without 1: 10 h
6
86% yield
>99% ee  
Scheme 6.2. Proline-catalyzed Mannich reaction between propionaldehyde and 
benzaldehyde N-Boc imine. 
 
Solubility Studies.  We considered the possibility that the observed rate 
enhancement may be due to an increased solubility of proline in the presence of 1 
rather than faster enamine formation.  Indeed, Hayashi has shown that a more soluble 
proline derivative displays greater catalytic activity than proline in the α-
aminoxylation of carbonyl species.10,37-40  However, when proline and 1 were placed 
in ethyl acetate, no appreciable dissolution was observed after 48 hours, and there was 
no distinguishable difference in dissolution between the proline-urea case and the 
proline-only control.  We addressed this issue more quantitatively with a 1H NMR 
experiment in which we assessed the solubility of proline in CDCl3 by comparison 
against an internal standard (see Supporting Information).  Again, there was no 
difference in the extent of proline dissolution for the urea and non-urea cases; the 
observed solubility in both cases was approximately 0.0045 M, in agreement with 
previously reported results.22  These findings suggest that urea 1 does not directly 
solubilize proline but instead provides rate enhancement through a different 
mechanism. 
Further evidence against the role of urea 1 in proline dissolution is provided by 
the persistence of rate enhancement by urea 1 even when catalyst dissolution cannot 
be a factor in the rate of α-aminoxylation.  When oxazolidinone 7 (intermediate A in 
Scheme 6.1) was prepared from proline and hexanal and used as the catalyst, a 
significantly faster reaction is observed in the presence of 1 (Figure 6.3).  It is 
interesting to note that as does the proline-only case, the reaction using oxazolidinone 
7 alone exhibits autoinduction—although to a lesser extent—but that the addition of 
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urea 1 eliminates this phenomenon completely (Figure 6.3, inset).  The mechanistic 
implications of this observation are discussed below.  Furthermore, rate enhancement 
by urea 1 is also observed when an insoluble solid-supported proline is used in place 
of free proline.41  Because catalyst dissolution does not play a role in either of these 
reactions, it cannot be the reason for the rate enhancement imparted by 1. 
 
 
Figure 6.3. Oxazolidinone 7-catalyzed α-aminoxylation of hexanal: with 1 (●) and 
without 1 (○). 
 
 Origin of Rate Enhancement.  While exploring the use of proline derivatives 
in this reaction, we observed that the presence of urea 1 did not enhance the rate of α-
aminoxylation when pyrrolidine-tetrazole 8 was used as the catalyst (Figure 6.4).42   
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Figure 6.4. Pyrrolidine-tetrazole-catalyzed α-aminoxylation of hexanal: with 1 (●) 
and without 1 (○). 
 
 The absence of rate enhancement in this case is not consistent with a scenario 
involving the electrophile activation that has been implicated in other cases of urea 
catalysis,26-29 because aldehyde activation by the urea would be expected to provide 
rate enhancement independent of pyrrolidine structure.  A similar argument can be 
made against the activation of nitrosobenzene.  Instead, this observation strongly 
suggests that the urea promotes enamine formation through a different mechanism. If 
oxazolidinones are indeed productive intermediates in the α-aminoxylation pathway, 
the rate enhancement that we observe may be due to interaction between the 
oxazolidinone and urea 1.  Specifically, this hydrogen bonding could enhance the 
oxazolidinone carboxylate’s ability to act as a leaving group, resulting in faster 
















Figure 6.5. Proposed interaction between bifunctional urea 1 and oxazolidinone 
intermediate. 
 
 The results shown in Figure 6.4 also support our hypothesis; since the 
pyrrolidine-tetrazole cannot form an oxazolidinone species,43 the urea cannot provide 
rate enhancement through the proposed mechanism.  On the other hand, when 
carboxylate-containing siloxyproline 944 was employed as the catalyst, rate 
enhancement was again observed upon the addition of urea 1 (Figure 6.6), again 
implicating the role of the oxazolidinone in the origin of rate enhancement.  
 
 
Figure 6.6. Soluble proline 9-catalyzed α-aminoxylation of hexanal: with 1 (●) and 
without 1 (○). 
 To further explore this hypothesis, we looked at the influence the amine tether 
has on the rate of α-aminoxylation.  Increasing the tether by one methylene resulted in 
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a reaction that was twice as fast as with urea 1, while altering the conformation with a 
2,2-dimethylpropyl tether decreased the rate of reaction (see Supporting Information).  
Further studies to probe these interactions are in progress, but these preliminary results 
suggest that the position and accessibility of the amine play an important role in the 
observed rate enhancement. 
The results presented above certainly do not preclude the possibility for the 
participation of urea 1 in a step other than enamine formation.  It is plausible that 1 
instead accelerates a different step such as the proposed exchange between the 
product-proline complex and the enamine.  However, the observation of rate 
enhancement in the proline-catalyzed Mannich reaction, which does not exhibit 
autoinduction, strongly suggests that the urea is involved in a step that takes place 
prior to entering the autoinductive pathway.  Based on this, we propose the catalytic 
cycle shown in Scheme 6.3, which is consistent with our results as well as those 
presented by others.  Because we observe the same behavior regardless of whether we 
start with free proline or with oxazolidinone A (water was not observed by 1H NMR), 
we can simplify the pathway by eliminating both free proline and the water that is 
liberated from its condensation with the aldehyde. 
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Scheme 6.3. Proposed catalytic cycle for the α-aminoxylation of aldehydes based on 
the rate enhancement provided by urea 1.   The cycle contains an autoinductive 
pathway (dashed lines, without urea 1) and a non-autoinductive pathway (solid lines, 
with urea 1). 
 Like Blackmond, we suggest the existence of two possible pathways in the α-
aminoxylation catalytic cycle, with one (inner pathway) involving the transformation 
of a proline-product complex directly to the enamine.  However, because no water is 
present to effect the release of product by hydrolysis, we propose that this complex is 
actually the iminium species C that is generated by the addition of nitrosobenzene to 
enamine B.  Conversion of C to B with the concomitant release of product may 
proceed by the mechanism shown in Scheme 6.4.  Though 2+2 cycloadditions are 
thermally unfavored for the formation of carbocycles, 2+2 cyclizations involving 
carbonyls are known.45  In addition, preliminary calculations for such a transformation 
indicate a favorable ΔG° (see Supporting Information).  Such a mechanism could 
explain why autoinduction is observed in some proline-catalyzed reactions but not in 
others, since the properties of the added electrophile should play a role in determining 
whether this exchange is possible.  In cases for which it is not possible, reactions such 
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Scheme 6.4. Proposed mechanism for the iminium-enamine exchange in the α-
aminoxylation autoinductive pathway. 
 
 In the context of this model, the explanation for the autoinduction that is 
observed in the proline-only case is the same as that previously proposed by 
Blackmond: the reaction proceeds slowly in the beginning due to slow enamine 
formation from the starting oxazolidinone A but becomes faster as the enamine is 
generated more rapidly through the inner cycle.  On the other hand, when urea 1 is 
present, we propose that enamine formation is accelerated enough to allow the outer 
pathway to dominate.  For this model to be valid, both the transformation from 
oxazolidinone A to enamine B as well as the oxazolidinone exchange between E and 
A along the outer pathway must be faster (when the urea is present) than the iminium-
enamine conversion along the inner pathway.  If not, the inner pathway would be 
expected to dominate and the autoinduction would persist.  It is plausible that the 
transformation from E to A is fast, as oxazolidinone exchange has been shown to 
occur freely,22,43 and we propose that urea 1 accelerates the transformation from 
oxazolidinone A to enamine B enough so that the change from the inner to the outer 
pathway can occur. 
Evidence to support our proposed model is seen in the oxazolidinone 7-
catalyzed α-aminoxylation, for which the presence of urea 1 eliminates the 
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autoinduction that is seen in the proline-only case. 1 appears to sufficiently enhance 
the rate of enamine formation so that the outer pathway dominates, making the 
autoinductive inner pathway unimportant.  An argument can be made that the urea 
sufficiently accelerates the reaction that the exchange between iminium C and 
enamine B becomes rate-limiting, as has been proposed for the outer pathway.23  This 
would indeed eliminate autoinduction while allowing the reaction to proceed through 
the inner pathway.  However, this would also result in the proline-only and proline-
urea cases exhibiting the same rate.  Even at its fastest, the proline-only reaction does 
not achieve the same rate as the proline-urea reaction, indicating that the latter 
proceeds via a different pathway.  Also consistent with the model presented in Scheme 
3 are the unchanged selectivities that we observe when urea 1 is present: since 
selectivity is determined during a step that is common to both pathways, the 
enantioselectivity should be the same regardless of which pathway is operative.   
 
Conclusion 
In summary, we have reported that the proline-catalyzed α-aminoxylation of 
aldehydes is enhanced by the presence of bifunctional urea 1, which exhibits high 
reaction rates in a more benign solvent while still providing high enantioselectivities 
and yields.  Our results suggest that 1 promotes enamine formation by interacting with 
the oxazolidinone intermediate, supporting the role of the oxazolidinone as a 
productive catalytic species.  Our observation that urea 1 removes the autoinductive 
behavior typically seen in proline-catalyzed α-aminoxylations has allowed us to 
provide a model that is consistent with both the proline-only and proline-urea cases.  
We propose that the enhanced enamine formation that we observe will allow for the 




 Though we were expecting the observed rate enhancement to be due to urea-
aldehyde interaction, the urea-oxazolidinone interaction that our results suggest 
provided us with an even richer system to study.  Though this project was based on the 
mistaken assumption that the bifunctional urea provided rate enhancement for the 
Michael addition discussed in Chpaters 3-5, our seemingly random choice of a follow-
up reaction serendipitously led to some interesting findings. Our exploration of this 
system led to a greater understanding of the role of the oxazolidinone intermediate, as 
well an explanation of the autoinductive pathway that is present in the α-




 All reagents were used without purification unless otherwise noted.  
Nitrosobenzene was recrystallized from ethanol prior to use.  Ethyl phenyl urea was 
recrystallized from ethyl acetate prior to use.  Propionaldehyde, hexanal, and octanal 
were vacuum distilled prior to use.  Reactions were rocked on a Thermolyne Speci-
Mix test tube rocker where indicated.  Gas chromatographic (GC) analyses were 
performed using an Agilent 7890A GC equipped with an Agilent 7683B autosampler, 
a flame ionization detector (FID), and a J&W Scientific 19091J-413 column (length = 
30 m, inner diameter = 320 µm, and film thickness = 250 µm).  The temperature 
program for GC analysis held the temperature constant at 80 oC for 1 min, heated 
samples from 80 to 200 oC at 25 oC/min and held at 200 oC for 1.5 min.  Inlet and 
detector temperatures were set constant at 250 and 300 oC, respectively.  Mesitylene 
was used as an internal standard to calculate reaction conversion.  1H NMR and 13C 
NMR spectra were recorded in CDCl3 on Varian Mercury 300MHz operating at 
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300.070 MHz and 75.452 MHz, respectively, using the residual solvent peak as 
reference.  Data are reported as s = singlet, d = doublet, t = triplet, m = multiplet, q = 
quadruplet.  High performance liquid chromatography (HPLC) was performed using a 
Varian Pro Star chromatograph using a CHIRALPAK IA column (250 mm x 4.6 mm) 
and CHIRALPAK IA guard column (1 cm x 0.4 cm).  Retention times for R and S 
isomers were determined by using (DL)-proline instead of (L)-proline in the general 
procedure.  All chromatograms were obtained using a wavelength of 254 nm. 
 
1-(2-(dimethylamino)ethyl)-3-phenylurea (1).  Prepared as described in the 
Experimental Section of Chapter 5. 
 
N-(2-(dimethylamino)ethyl)ethanamide (4). Prepared as described in the 
Experimental Section of Chapter 5. 
 
General Procedure for α-Aminoxylation of Hexanal with Additives 1-4.  A 
solution of additive (0.05 mmol, 0.05 eq) in 1 mL solvent was added to (L)-proline 
(5.8 mg, 0.05 mmol, 0.05 eq) in a 1 dram screw cap vial.  The vial was sonicated for 1 
min and held at 4 oC for 15 min.  1 mL of a stock solution of nitrosobenzene (1 M), 
hexanal (3 M), and mesitylene (0.1 M) was added and the reaction was rocked at 4 oC.  
Reaction conversion was monitored by withdrawing aliquots from the reaction, 
diluting into ethyl acetate, and analyzing by GC with reference to mesitylene.  Yields 
at 40 minutes were determined using calibrated GC results. 
 
General Procedure for α-Aminoxylation of Aldehydes. Nitrosobenzene (214 mg, 
2.0 mmol, 1.0 eq), (L)-proline (11.6 mg, 0.1 mmol, 0.05 eq) and urea 1  (20.8 mg, 0.1 
mmol, 0.05 eq) were added to a 2 dram screw cap vial equipped with a stir bar.  Ethyl 
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acetate (4 mL) was added to the vial, upon which the reaction mixture turned green.  
The reaction mixture was submerged in an ice bath and stirred for 15 min.  The 
appropriate aldehyde (6.0 mmol, 3.0 eq) was added to the reaction mixture in one 
portion at 0 ˚C.  The reaction mixture was continuously stirred at 0 ˚C until the 
reaction color changed from green to yellow and the reaction was determined to be 
complete by GC.  The reaction was transferred to a suspension of sodium borohydride 
(300 mg, 8.0 mmol, 4.0 eq) in ethanol (10 mL) at 0 ˚C.  An additional 5 mL of ethanol 
was used to rinse the reaction vessel and added to the sodium borohydride suspension.  
After 20 min, the reaction mixture was poured into a separatory funnel containing 25 
mL saturated aqueous NaHCO3 and the aqueous phase extracted with EtOAc (3 x 20 
mL).  The combined organic extracts were dried with MgSO4, filtered, concentrated in 
vacuo, and dried under vacuum.  The resulting residue was purified using column 
chromatography to afford the desired compounds.  Enantioselectivities were 
determined using chiral HPLC analysis. 
 
(R)-2-(N-Phenyl-aminooxy)-hexan-1-ol (5a). Prepared according to the general 
procedure using hexanal (750 µL, 6.0 mmol, 3.0 eq) for 2 h to afford the title 
compound as a yellow oil (400 mg, 96 % yield, 99 % ee) after column chromatography 
(silica gel, 4:1 hexanes/EtOAc, Rf = 0.18). 1H NMR (300 MHz, CDCl3) δ 7.28 (m, 
2H), 6.99 (m, 2H), 3.95 (m, 1H), 3.81 (m, 2H), 2.50 (bs, 1H), 1.68 (m, 1H), 1.40 (m, 
6H), 0.93 (t, 3H); 13C NMR (75 MHz, CDCl3) δ 148.7, 129.0, 122.1, 114.6, 84.0, 
64.7, 29.7, 28.0, 22.9, 14.0.  The enantiomeric ratio was determined by HPLC using a 
CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 
15.0 min and (R) isomer tr= 17.6 min. 
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(R)-2-(N-Phenyl-aminooxy)-propan-1-ol (5b).  Prepared according to the general 
procedure using propionaldehyde (437 µL, 6.0 mmol, 3.0 eq) for 3 h to afford the title 
compound as a yellow oil (300 mg, 90 % yield, 98 % ee) after column chromatography 
(silica gel, 4:1 hexanes/EtOAc, Rf = 0.09).  1H NMR (300 MHz, CDCl3) δ 7.28 (m, 
2H), 7.00 (m, 3H), 4.13 (m, 1H), 3.76 (m, 2H), 1.26 (d, 3H); 13C NMR (75 MHz, 
CDCl3) δ 148.8, 131.1, 129.1, 122.1, 80.2, 65.8, 15.5.  The enantiomeric ratio was 
determined by HPLC using a CHIRALPAK IA and IA guard column (5 % 
IPA/hexanes, 1 mL/min); (S) isomer tr= 20.2 min and (R) isomer tr= 22.0 min. 
 
(R)-3-methyl-2-(N-Phenyl-aminooxy)-butan-1-ol (5c). Prepared according to the 
general procedure using isovaleraldehyde (650 µL, 6.0 mmol, 3.0 eq) for 3.5 h to afford 
the title compound as a yellow oil (380 mg, 97 % yield, 99 % ee) after column 
chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.18). 1H NMR (300 MHz, 
CDCl3) δ 7.28 (m, 2H), 7.03 (bs, 1H), 7.01 (m, 3H), 3.88 (m, 2H), 3.75 (m, 1H), 2.84 
(bs, 1H), 2.04 (m, 1H), 1.04 (dd, 6H); 13C NMR (75 MHz, CDCl3) δ 148.6, 129.1, 
122.5, 115.1, 88.7, 63.4, 28.8, 18.9, 18.7.  The enantiomeric ratio was determined by 
HPLC using a CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); 
(S) isomer tr= 13.4 min and (R) isomer tr= 15.4 min. 
 
(R)-2-(N-Phenyl-aminooxy)-octan-1-ol (5d). Prepared according to the general 
procedure using octanal (940 µL, 6.0 mmol, 3.0 eq) for 5 h to afford the title 
compound as a yellow oil (400 mg, 84 % yield, 99 % ee) after column chromatography 
(silica gel, 4:1 hexanes/EtOAc, Rf = 0.14). 1H NMR (300 MHz, CDCl3) δ 7.28 (m, 
2H), 7.00 (m, 4H), 3.95 (m, 1H), 3.78 (m, 2H), 2.62 (bs, 1H), 1.48 (m, 10H), 0.91 (t, 
3H); 13C NMR (75 MHz, CDCl3) δ 148.7, 129.0, 122.2, 114.8, 84.1, 64.8, 31.8, 30.1, 
29.3, 25.9, 22.7, 14.2.  The enantiomeric ratio was determined by HPLC using a 
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CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 
13.9 min and (R) isomer tr= 16.0 min. 
 
(R)-3-phenyl-2-(N-Phenyl-aminooxy)-propan-1-ol (5e). Prepared according to the 
general procedure using 3-phenylpropionaldehyde (793 µL, 6.0 mmol, 3.0 eq) for 3.5 h 
to afford the title compound as a yellow oil (410 mg, 84 % yield, >99 % ee) after 
column chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.09). 1H NMR (300 
MHz, CDCl3) δ 7.18 (m, 7H), 6.97 (bs, 1H), 6.86 (t, 1H), 6.78 (d, 2H), 4.08 (m 1H), 
3.78 (m, 1H), 3.66 (m, 1H), 3.02 (dd, 1H), 2.80 (dd, 1H), 2.38 (bs, 1H); 13C NMR (75 
MHz, CDCl3) δ 148.5, 138.0, 129.6, 1291, 128.6, 126.6, 122.3, 114.7, 85.2, 64.0, 
36.6.  The enantiomeric ratio was determined by HPLC using a CHIRALPAK IA and 
IA guard column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 25.8 min and (R) isomer 
tr= 31.2 min. 
 
(R)-2-phenyl-2-(N-Phenyl-aminooxy)-ethan-1-ol (5f). Prepared according to the 
general procedure using phenylacetaldehyde (766 µL, 6.0 mmol, 3.0 eq) for 2 h to 
afford the title compound as a yellow oil (250 mg, 55 % yield, 99 % ee) after column 
chromatography (silica gel, 4:1 hexanes/EtOAc, Rf = 0.20). 1H NMR (300 MHz, 
CDCl3) δ  7.30 (m, 7H), 7.00 (m, 4H), 5.03 (dd, 1H), 3.98 (m, 1H), 3.86 (m, 1H), 2.58 
(bs, 1H); 13C NMR (75 MHz, CDCl3) δ 148.1, 138.0,  129.1, 128.7, 128.6, 127.2, 
122.5, 115.0, 86.6, 66.1.  The enantiomeric ratio was determined by HPLC using a 
CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); (S) isomer tr= 
25.9 min and (R) isomer tr= 28.9 min. 
 
(R)-2-(N-Phenyl-aminooxy)-pent-4-en-1-ol (5g). Prepared according to the general 
procedure using 4-pentenal (621 µL, 6.0 mmol, 3.0 eq) for 2.5 h to afford the title 
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compound as a yellow oil (290 mg, 75 % yield, 99 % ee) after column chromatography 
(silica gel, 4:1 hexanes/EtOAc, Rf = 0.14). 1H NMR (300 MHz, CDCl3) δ 7.28 (m, 
2H), 7.05 (s, 1H), 7.00 (m, 3H), 5.89 (m, 1H), 5.14 (dt, 2H), 4.04 (m, 1H), 3.89 (m, 
2H), 2.94 (m, 1H), 2.38 (m, 2H); 13C NMR (75 MHz, CDCl3) δ 148.6, 134.2, 129.2, 
122.6, 117.9, 114.9, 83.5, 64.6, 34.8.  The enantiomeric ratio was determined by 
HPLC using a CHIRALPAK IA and IA guard column (5 % IPA/hexanes, 1 mL/min); 
(S) isomer tr= 20.2 min and (R) isomer tr= 23.1 min. 
 
Benzaldehyde N-Boc Imine.  Prepared according to the method of Wenzel et al.46  
tert-Butyl carbamate (1.0 g, 8.6 mmol) and benzenesulfinic acid sodium salt (2.8 g, 17 
mmol) were suspended in a solution of MeOH and water (1:2, 25 mL).  Benzaldehyde 
(1.3 mL, 12.8 mmol) was added in one portion, followed by formic acid (88%, 7.1 
mL), and the reaction was stirred at room temperature for 2 days.  The resulting white 
product was isolated by filtration, washed with water, and dried under vacuum to give 
N-(tert-butoxycarbonyl)-α-(phenylsulfonyl)benzylamine as a white solid (2.77 g, 
93.9% yield): 1H NMR (300 MHz, CDCl3): δ 7.92 (d, 2H), 7.63 (t, 1H), 7.57 (t, 2H), 
7.42 (m, 5H), 5.93 (bd, 1H), 5.76 (bd, 1H), 1.24 (s, 9H).  K2CO3 (4.1 g, 29.8 mmol) 
and Na2SO4 (4.96 g) were placed in a round bottom flask containing a stir bar.  The 
solids were placed under vacuum and flame-dried.  Once cool, N-(tert-
butoxycarbonyl)-α-(phenylsulfonyl)benzylamine (1.72 g, 5 mmol) was added under a 
stream of N2, followed by THF (46 mL).  The reaction was stirred at reflux under an 
atmosphere of N2 for 16 h.  The reaction was cooled and the solids were removed by 
filtration.  The filtrate was concentrated and dried under vacuum to give benzaldehyde 
N-Boc imine as a colorless oil (1.02 g, quant): 1H NMR (CDCl3, 300 MHz); δ 8.89 (s, 
1H), 7.92 (d, 2H), 7.58 (t, 1H), 7.49 (t, 2H), 1.61 (s, 9H). 
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General Procedure for Mannich Reaction Between Propionladehyde and N-Boc 
Imine.  Adapted from the method of Yang et al.47  A solution of additive (0.05 mmol, 
0.05 eq) in 1 mL solvent was added to (L)-proline (5.8 mg, 0.05 mmol, 0.05 eq) in a 1 
dram screw cap vial.  The vial was sonicated for 1 min and stirred at 0 oC for 15 min.  
1 mL of a stock solution of benzaldehyde N-Boc imine (1.0 M) and mesitylene (0.1 M) 
was added, followed by propionaldehyde (72.2 µL, 4 mmol, 4 eq) and the reaction was 
stirred at 0 oC.  Reaction conversion was monitored by withdrawing aliquots from the 
reaction, diluting into dichloromethane, and analyzing by GC with reference to 
mesitylene. 
 
tert-Butyl (2S)-2-methyl-3-oxo-1-phenylpropylcarbamate (6).  Prepared according 
to the procedure described above.  After the reaction was complete, it was quenched 
into water and extracted with ether (3x).  The combined organic layers were dried over 
Na2SO4, filtered, and concentrated.  HPLC analysis was performed prior to 
recrystallization from hexanes and ether. 1H NMR (300 MHz, CDCl3) δ 9.71 (s, 1H), 
7.38-7.23 (m, 5H), 5.09 (m, 2H), 2.91 (m, 1H), 1.42 (s, 9H), 1.05 (d, 3H); 13C NMR 
(75 MHz, CDCl3) δ 203.2, 155.3, 129.0, 127.8, 126.8, 80.3, 54.9, 51.8, 28.5, 9.4.  The 
enantiomeric ratio was determined by HPLC using a CHIRALPAK IA and IA guard 
column (10 % IPA/hexanes, 1 mL/min); tr= 8.2 min and 9.8 min. 
 
Preparation of Oxazolidinone 7.  Preparation of oxazolidinone 7 was modified from 
the literature.21  Hexanal (123 µL, 1 mmol) and proline (115.2 mg, 1 mmol) and 4 Å 
molecular sieves (139 mg) were stirred in CDCl3 (5 mL) under an environment of N2 
for 14 hours.  Catalyst concentration was assessed by 1H NMR using mesitylene as an 
internal standard.  Typical concentrations were 0.02-0.05 M. 
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α-Aminoxylation of Hexanal with Oxazolidinone 7.  Urea 1 (10.4 mg, 0.05 mmol, 
0.05 eq), CHCl3 (volume varied depending on concentration of oxazolidinone 7) and 4 
Å molecular sieves (35 mg) were stirred at 0 oC for 10 min.  Propionaldehyde (370 µL, 
3 mmol, 3 eq) was added, followed by a stock solution (1 mL) of nitrosobenzene (1 M) 
and mesitylene (0.1 M) in CHCl3.  Oxazolidinone 7 in CDCl3 (volume varied depending 
on concentration) was added, and reaction conversion was monitored by withdrawing 
aliquots from the reaction at different time intervals, diluting into ethyl acetate, and 
analyzing by GC with reference to mesitylene.  The control reaction was performed in 
the same way but without urea 1. 
 
α-Aminoxylation of Hexanal with Pyrrolidine Tetrazole 8.  Pyrrolidine-tetrazole 8 
(7.0 mg, 0.05 mmol), urea 1 (10.4 mg, 0.05 mmol) and EtOAc (1 mL) were sonicated 
in a 1 dram screw cap vial for 1 min.  A stock solution (1 mL) of hexanal (3 M), 
nitrosobenzene (1 M), and mesitylene (0.1 M) in EtOAc was added and the reaction 
was rocked at 22 oC.  Reaction conversion was monitored by withdrawing aliquots 
from the reaction at different time intervals, diluting into ethyl acetate, and analyzing 
by GC with reference to mesitylene.  The control reaction was performed in the same 
way but without urea 1. 
 
Preparation of (4R)-4-(t-butyldimethylsilyloxy)-L-proline (9).  Siloxyproline 9 was 
prepared as reported in the literature.11,44  N-Cbz-hydroxy-L-proline (1.5 g, 5.7 mmol), 
benzyl bromide (0.67 mL, 5.7 mmol), K2CO3 (781 mg, 5.7 mmol), and NaI (84.7 mg, 
0.57 mmol) were stirred in DMF (5 mL) at room temperature for 16 h.  The reaction 
was quenched by slow addition of saturated LiBr (5 mL) and acidified with 1 M HCl.  
The product was extracted with CH2Cl2 (3 x 20 mL), dried over Na2SO4, and 
concentrated.  The remaining DMF was removed by vacuum distillation and the 
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product was purified by column chromatography (silica, 95:5 CHCl3:MeOH) to give 
(4R)-N-Cbz-4-hydroxy-L-proline benzyl ester (2.01 g, quant): 1H NMR: δ 7.39-7.22 
(m, 10H), 5.22-5.15 (m, 2H), 5.07-4.99 (m, 2H), 4.61-4.44 (m, 2H), 3.77-3.25 (m, 
3H), 2.39-2.23 (m, 1H), 2.18-2.07 (m, 1H).  (4R)-N-Cbz-4-hydroxy-L-proline benzyl 
ester (1.96 g, 5.5 mmol), TBDMSCl (1 g, 6.6 mmol), and imidazole (450 mg, 6.6 
mmol) were stirred in DMF (25 mL) at room temperature for 16 h.  The solvent was 
removed by vacuum distillation and the resulting white solid was taken up in H2O (25 
mL).  The product was extracted with CHCl3 (3 x 25 mL), dried over Na2SO4, and 
concentrated.  The product was purified by column chromatography (silica, 95:5 
CHCl3:MeOH) to give (4R)-N-Cbz-4-(t-butyldimethylsilyloxy)-L-proline benzyl ester 
(2.12 g, 82% yield): 1H NMR (CDCl3, 300 MHz): δ 7.39-7.21 (m, 10H), 5.22-4.96 (m, 
4H), 4.60-4.41 (m, 2H), 3.72-3.63 (m, 1H), 3.55-3.42 (m, 1H), 2.26-2.17 (m, 1H), 
2.10-2.00 (m, 1H), 0.83 (s, 9H), 0.03 (s, 6H).  (4R)-N-Cbz-4-(t-
butyldimethylsilyloxy)-L-proline benzyl ester (1.98 g, 4.2 mmol), Pd/C (palladium, 10 
wt% (dry basis) on activated carbon, wet, Degussa type E101 NE/W, 1 g), and MeOH 
(20 mL) were stirred under a balloon of H2 for 4 h.  The Pd/C was filtered off over 
Celite and the product was concentrated to give crude product.  The product was 
dissolved in a small amount of MeOH and triturated with EtOAc to give (4R)-4-(t-
butyldimethylsilyloxy)-L-proline as a white solid: 1H NMR (CD3OD, 300 MHz): δ 
4.63 (m, 1H), 4.51 (dd, 1H), 3.50 (dd, 1H), 3.26 (m, 1H), 2.39 (m, 1H), 2.23 (m, 1H), 
0.92 (s, 1H), 0.17 (s, 3H), 0.16 (s, 3H); 13C NMR (CD3OD, 75 MHz): δ 171.6, 72.7, 
59.9, 55.7, 39.6, 26.3, 19.0, -4.7, -4.8. 
 
α-Aminoxylation of Hexanal with Siloxyproline 9.  Siloxyproline 9 (12.3 mg, 0.05 
mmol, 0.05 eq), urea 1 (10.4 mg, 0.05 mmol, 0.05 eq), and acetonitrile (1 mL) were 
placed in a 1 dram screw cap and stirred at 0 oC for 15 min.  A stock solution (1 mL) 
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of nitrosobenzene (1 M) and mesitylene (0.1 M) in acetonitrile was added, followed by 
hexanal (370 µL, 3 mmol, 3 eq) and the reaction was stirred at 0 oC.  Reaction 
conversion was monitored by withdrawing aliquots from the reaction at different time 
intervals, diluting into ethyl acetate, and analyzing by GC with reference to 
mesitylene.  The control reaction was performed in the same way but without urea 1. 
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Figure A1.2.  Optical micrograph of swollen capsules in methanol.  The scale bar is 
50 µm. 
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Preliminary evidence for trans-β-Nitrostyrene (4) binding to the µcaps 
 
  In order to account for the lost material in cases where conversion of 
benzaldehyde was not quantitative we did a trans-β-nitrostyrene (4) binding 
experiment to the µcaps.  Based on literature reports of nitroalkenes reacting in a 
Michael-type reaction with primary and secondary amines1-4, we hypothesized that the 
µcaps were removing nitrostyrene from our reaction mixture in a similar fashion.  
Briefly, µcaps (30 mg) swollen in methanol (0.1 mL) were dispersed in toluene (0.5 
mL) and trans-β-nitrostyrene, 4 (150 mg, 1 mmol) was added to the mixture followed 
by mesitylene (13.7 µL, internal standard).  Nitrostyrene concentration was followed 
over time with GC. 
 
 
Figure A1.3.  Components of the monitored mixture: nitrostyrene, toluene, µcaps 




As it can be seen from the Figure A1.3 trans-β-nitrostyrene (4) is removed from the 
reaction mixture with µcaps through an unproductive pathway.  This is avoided if 
nitrostyrene is promptly directed to the Michael adduct (6) with the second catalyst 





  In order to quantify how much of the nickel catalyst (2) is being degraded by 
µcap catalyst (1), UV-Vis absorbance of the nickel catalyst was monitored over time 
in the presence and in the absence of the µcaps.  To nickel catalyst (2, 60 mg), 
dissolved in toluene (1 mL), µcap catalyst (1, 15 mg) slurry in methanol (0.5 mL) was 
added.  Absorbance at 394 and 656 nm was followed over time.  The control 
experiment consisted of measuring absorbance at the same wavelengths of the nickel 
catalyst solution without the µcap catalyst present.  Percent nickel catalyst was 
normalized to the relative absorbance at time zero.  Percentages were averaged over 
the two wavelengths.  Results, shown in the Figure A1.4, suggest that the µcaps 
degrade nearly 20% of the initial nickel catalyst within 40 hours.  On the other hand, 
the control also shows 10% degradation.  Therefore, µcap catalyst is responsible of 











Figure A1.4.  Percent nickel catalyst degradation as a function of time: A) in the 
presence of µcaps, and B) in the absence of µcaps. 
 
 
Qualitative assessment of nickel catalyst interaction with µcaps and free PEI 
 
  To nickel catalyst (2, 60 mg) dissolved in toluene (1 mL), either µcap catalyst 
(1, 30 mg) or, as a control, free PEI (30 mg) was added.  Color change was captured 




Figure A1.5.  Qualitative assessment of nickel catalyst interaction with µcaps and free 
PEI: µcaps, two solutions of nickel catalyst, and free PEI (A), µcaps being added to 
the nickel catalyst solution (B), free PEI being added to the nickel catalyst solution 




Michael addition in the presence and absence of microencapsulated PEI (1) 
 
  The Michael addition between trans-β-nitrostyrene (4) and dimethyl malonate 
was performed in the presence and absence of microencapsulated PEI (1) in order to 
determine if the presence of the µcaps decreases the catalytic activity of the nickel 
catalyst (2).  In order to prevent the binding of trans-β-nitrostyrene to the µcaps, the 
primary amines of the µcaps were acylated with acetic anhydride.  The Michael 
additions were performed as followed: to either a vial containing 30 mg acylated 
µcaps swollen in 0.5 mL MeOH, a vial containing 30 mg of untreated µcaps swollen 
in 0.5 mL MeOH, or a vial containing 0.5 mL MeOH was added trans-β-nitrostyrene 
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(4) (149.2 mg, 1 mmol), nickel catalyst 2 (16.2 mg, 2.0 mol%), and toluene (1 mL).  
The vial was sealed with a screw cap and he reaction was rocked at room temperature 
on a rocker. Reaction conversion was monitored by withdrawing aliquots from the 
reaction at different time intervals, diluting with methylene chloride, and analyzing by 
GC with reference to mesitylene. 
 
 
Figure A1.6.  Uncorrected data from the Michael addition between trans-β-
nitrostyrene (4) and dimethyl malonate in the presence of acylated µcaps (A), in the 
presence of untreated µcaps (B), and in the absence of µcaps (C). 
 
 
It can be seen that in both cases where µcaps are present (Figure A1.6, A and 
B), there is an initial rate enhancement compared to the control (Figure A1.6, C).  The 
reaction with acylated µcaps (Figure A1.6, A) maintains this rate enhancement 
throughout the entire reaction while the reaction with untreated µcaps levels off after 
60% conversion.  This is due to 4 binding irreversibly to the µcaps and being rendered 
unavailable for conversion to 6.  This effect can be corrected for by reporting the 
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normalized yield of 6: (moles of 6)/(moles of 4 + moles of 6).  These results are shown 
in Figure A1.7. 
 
 
Figure A1.7.  Corrected data from the Michael addition between trans-β-nitrostyrene 
(4) and dimethyl malonate in the presence of acylated µcaps (A), in the presence of 
untreated µcaps (B), and in the absence of µcaps (C).  Data from cases A and C have 
not been modified.  Data from case B has been standardized to account for the 
irreversible binding of starting material to µcaps.   
 
 
When the results for the untreated µcaps are corrected, it can be seen that 
acylated (Figure A1.7, A) and untreated (Figure A1.7, B) µcaps demonstrate similar 
rate enhancement.  More importantly, µcap presence does not decrease the overall 
yield, as all three cases remain stable at 90% yield of 6 past the 10 hour point.  If the 
nickel catalyst were able to interact with the encapsulated PEI, we would expect to see 
a dramatic decrease in yield of 6, as is observed in the control experiments. Negligible 
(0-5%) yield of 6 is obtained in control experiments (not shown) employing µcaps 
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APPENDIX 2 
Supporting Information for Chapter 4 
 
Microcapsule-catalyzed reaction in different solvents 
 
 General Procedure: Either free PEI (15 mg, 13.8 mole %) or encapsulated PEI 
(1, 30 mg, 26.4 mole %) was placed in a 4 mL glass vessel.  Solvent (1 mL) was 
added, and the vessel was sealed and allowed to stand at room temperature overnight.  
Benzaldehyde (4, 101.6 µL, 1 mmol), nitromethane (0.54 mL, 10 mmol), and 
mesitylene (13.9 µL, 0.1 mmol) were added.  The vessel was sealed and the reaction 
was rocked at room temperature on a rocker.  Reaction conversion was monitored by 
withdrawing aliquots from the reaction at different time intervals, diluting with 




Figure A2.1. Conversion of benzaldehyde (4) after 6 hours for the amine-catalyzed 
reaction between benzaldehyde and nitromethane.  Catalysts for the reaction were free 





Evidence against nitroalcohol intermediate 
 
2-nitro-1-phenylethanol.  The title compound was prepared according to the 
following procedure: Benzaldehyde (4, 0.48 mL, 4.7 mmol), nitromethane (0.5 mL, 
9.2 mmol), triethylamine (6 drops), and EtOH (0.54 mL) were stirred at room 
temperature for 18 hours.  The volatile components were removed under reduced 
pressure and the crude product was purified by column chromatography (20% 
EtOAc/hexanes).  1HNMR (400 MHz, CDCl3) δ 7.46-7.41 (m, 5H), 5.52-5.48 (dd, 
1H), 4.66-4.62 (dd, 1H), 4.58-4.53 (dd, 1H), 3.86 (s, 1H); 13CNMR (400 MHz, 
CDCl3) δ 138.4, 129.2, 129.1, 126.2, 81.4, 71.2. 
 
  Microencapsulated PEI catalyst (1, 25 mg, 11.5 mol %) was swollen in 1 mL 
methanol in a 4 mL glass vessel before use. 2-nitro-1-phenylethanol (167 mg, 1 mmol) 
and mesitylene were added to the vessel, which was sealed and rocked at room 
temperature on a rocker.  Reaction conversion was monitored by withdrawing aliquots 
from the reaction at different time intervals, diluting with methylene chloride, and 
analyzing by GC with reference to mesitylene.  No trans-β-nitrostyrene (5) formation 




Kinetic studies for tandem reaction 
 
Microencapsulated PEI catalyst (1, 25 mg, 3.83 mol %) was swollen in 0.5 mL 
methanol in a 4 mL glass vessel before use.  Nickel catalyst 2, aldehyde 8 (108.2 µL, 1 
mmol), nitromethane (0.54 mL, 10 mmol), dimethyl malonate (114.3 µL, 1 mmol), 
and toluene (1 mL) were added to the vessel, which was sealed with a screw cap.  The 
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reaction was rocked at room temperature on a rocker. Reaction conversion was 
monitored by withdrawing aliquots from the reaction at different time intervals, 




mg Ni cat mole % Ni cat rate (µmol 7i/min) std dev 
27.5 3.4 0.305 0.037 
55 6.8 0.520 0.031 
85 10.5 0.689 0.035 
110 13.6 0.915 0.029 
165 20.4 1.714 0.143 




Kinetic studies for Michael addition 
 
The 1o and 2o amines of microencapsulated catalyst 1 were acylated in the 
following manner: methanol (2.5 mL) was added to microcapsule catalyst (500 mg) 
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loaded in a syringe equipped with a frit.  Acetic anhydride (3 mL) was drawn into the 
syringe and the mixture was rocked at room temperature overnight.  The µcaps were 
washed with methanol and dried under vacuum before use. 
 
Acylated µcaps were swollen in 0.5 mL methanol in a 4 mL glass vessel before 
use.  Nickel catalyst (2, 16.2 mg, 2 mol %), trans-β-nitrostyrene (5, 149.2 mg, 1 
mmol), dimethyl malonate (137 µL, 1.2 mmol), and toluene (0.5 mL) were added to 
the vessel, which was sealed with a screw cap.  The reaction was rocked at 297 K on a 
rocker. Reaction conversion was monitored by withdrawing aliquots from the reaction 
at different time intervals, diluting with methylene chloride, and analyzing by GC with 
reference to mesitylene. 
 
Data Summary: 
mg µcaps mg µcaps Rate (mmol 7a/min) std dev 
0 0 0.0101 0.0003 
5 5 0.0122 0.0007 
15 15 0.0169 0.0008 






Supporting Information for Chapter 5 
 
Examination of additives for rate enhancement in the Michael Addition 
 
General Procedure: To trans-β-nitrostyrene (149.2 mg, 1 mmol), nickel 
catalyst 2 (16.2 mg, 0.02 mmol), and mesitylene (13.9 µL, 0.1 mmol) in solvent (1 mL) 
was added the appropriate polymer, urea, or amine.  Dimethyl malonate (137.1 µL, 1.2 
mmol) was added and the reaction was stirred at room temperature.  Reaction 
conversion was monitored by withdrawing aliquots from the reaction at different time 
intervals, diluting with methylene chloride, and analyzing by GC with reference to 
mesitylene. 
 
Table A3.1  Michael addition in the presence of urea and amine additives. 
Additive Amount Mol % Solvent krela 
4 31.2 mg 14.7 toluene 1.01 
5 24.1 mg 14.7 toluene 0.94 
6 15.0 mg — THF 0.81 
7 15.0 mg — CHCl3 1.64 
8 15.2 mg 7.3 CHCl3 2.66 
9 17.0 mg — CHCl3 1.54 
11 7.0 µL 5.0 CHCl3 2.07 




Michael addition: Order in amine 
 
 General Procedure: trans-β-Nitrostyrene (149.2 mg, 1 mmol), and mesitylene 
(13.9 mL, 0.1 mmol) were dissolved in CHCl3.  The amount of nickel catalyst 2 was 
held constant while the amount of amine 8 was varied (Table A3.2).  Dimethyl 
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malonate (137.1 µL, 1.2 mmol) was added and the reaction was stirred at room 
temperature.  Reaction conversion was monitored by withdrawing aliquots from the 
reaction at different time intervals, diluting with methylene chloride, and analyzing by 
GC with reference to mesitylene. 
 
Table A3.2.  Variation of nickel catalyst 2. 








Figure A3.1.  Order in amine 8 at nickel catalyst loadings of 0.5% (a), 1.0% (b), 2.0% 




Michael addition: Order in amine 
 
General Procedure: trans-β-Nitrostyrene (149.2 mg, 1 mmol), and mesitylene 
(13.9 mL, 0.1 mmol) were dissolved in CHCl3.  The amount of amine 8 was held 
constant while the amount of nickel catalyst 2 was varied (Table A3.3).  Dimethyl 
malonate (137.1 µL, 1.2 mmol) was added and the reaction was stirred at room 
temperature.  Reaction conversion was monitored by withdrawing aliquots from the 
reaction at different time intervals, diluting with methylene chloride, and analyzing by 
GC with reference to mesitylene. 
 
Table A3.3.  Variation of amine 8. 









Figure A3.2.  Order in nickel for amine loadings of 10% (), 3.5% (), 2.5% (), 







Method of continuous variation 
 
General Procedure: trans-β-Nitrostyrene (149.2 mg, 1 mmol), and mesitylene 
(13.9 mL, 0.1 mmol) were dissolved in CHCl3 (amount varies).  The total amount of 
amine 8 and nickel catalyst 2 was held constant while their ratio was varied.  Dimethyl 
malonate (137.1 µL, 1.2 mmol) was added and the reaction was stirred at room 
temperature.  Reaction conversion was monitored by withdrawing aliquots from the 
reaction at different time intervals, diluting with methylene chloride, and analyzing by 
GC with reference to mesitylene. 
 
 
Figure A3.3. Job plots, 2% total catalyst concentration for total solvent volumes of 0.2 
mL (a), 0.5 mL (b), 1.0 (c), and 2.5 mL (d). 
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 The general procedure was repeated using triethylamine (11) instead of amine 
8 to obtain the same results (Figure A3.4) 
 
 
Figure A3.4.  Job plot with triethylamine and nickel catalyst, 2% total catalyst 
loading, 1 mL solvent. 
 
 
Rate Model—1:1 Ratio 
 




where x represents the amount of complex 2•8 present in the reaction.  Equation A3.1 
can be rearranged to obtain 
 
 
Keqx2 – (Keq(2 + 8) + 1)x + Keq•2•8 = 0      (Equation A3.2) 
 
in the form ax2 + bx + c = 0, where a = Keq, b = -(Keq(2 + 8) + 1), and c = Keq•2•8.  The 





and the values for [2•8] (x) and [2] (2o-x) can be plugged into Equation A3.4 to model 
the rate. 




Rate Model—2:1 Ratio 
 




where x represents the amount of complex 2•8 present in the reaction.  Equation A3.5 
can be rearranged to obtain 
 
(Keq((2o - x)(8o - 2x)2)) - x = 0        (Equation A3.6) 
 
which can be solved in Microsoft Excel and plugged into Equation A3.4 or A3.7 to 
model the rate. 




Supporting Information for Chapter 6 
 
α-Aminoxylations of aldehydes in the presence of additives 
 
 General Procedure: The general procedure is described in the Experimental 









Examination of other ureas 
 
     General Procedure:  The reaction was performed as described in the general 




















a b c  
 




Mannich reaction between benzaldehyde N-Boc imine and propionaldehyde 
 
     Benzaldehyde N-Boc imine was prepared as reported in the literature.1 
 
     The Mannich reaction was modified from the procedure reported by Yang et al.2  A 
solution of additive (0.05 mmol, 0.05 eq) in 1 mL solvent was added to (L)-proline 
(5.8 mg, 0.05 mmol, 0.05 eq) in a 1 dram screw cap vial.  The vial was sonicated for 1 
min and stirred at 0 oC for 15 min.  1 mL of a stock solution of benzaldehyde N-Boc 
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imine (1.0 M) and mesitylene (0.1 M) was added, followed by propionaldehyde (72.2 
µL, 4 mmol, 4 eq) and the reaction was stirred at 0 oC.  Reaction conversion was 
monitored by withdrawing aliquots from the reaction, diluting into dichloromethane, 
and analyzing by GC with reference to mesitylene. 
 
Table A4.1.  Reaction times for Mannich reaction in the presence of additives. 
 
additive time (h) 
none 10 
urea 1 2.5 
ethyl phenyl urea 2 9 
N,N-dimethylethylamine 3 4 
2 + 3 2.5 
 
 
1H-NMR solubility studies 
 
     To (L)-proline (17.3 mg, 0.15 mmol) and urea (31.1 mg, 0.15 mmol) in a 1 dram 
screw cap vial was added mesitylene (5 mM in CDCl3).  As a control a vial was 
prepared in the same way without urea.  The vials were rocked at room temperature.  
After 2 h, the solution was filtered through a 0.45 µm PTFE membrane and assessed 
by 1H-NMR spectroscopy at 24 oC using the following parameters: 
 
 sfrq  300.073 
 tn  H1 
 at  1.666 
 np  16360 
 sw  4909.2 
 fb  not used 
 pw  10 
 tpwr  56 
 d1  60.000 
 tof  685.1 
 nt  1 










Figure A4.4. 1H NMR spectrum of proline. 
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Comparison of the aromatic mesitylene proton shift (δ = 6.80) with the proline proton 
at δ = 4.02 indicates that there is no difference in the extent of dissolution in the two 
cases: 
 
 mesitylene : proline proline concentration (M) 
proline + 1 3.00 : 0.87 0.0044 
proline only 3.00 : 0.94 0.0047 
 
Proline solubility of 0.0045 M is consistent with literature values.3 
 
 
Calculations for iminium-enamine exchange 
 
The 2+2 cycloadduct proposed in Scheme 4 was investigated using the 
following isodesmic equation.  The values provided were computed using the density 
functional B3LYP with a 3-21G basis set.  Thought this is a low level of theory 
performed in the gas phase, we feel that the relatively similar energies of the sum of 
the starting materials and product indicate that formation of the intermediate is 
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